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Abstract
Clinical Problem: Prostate cancer is the most common cancer among men in the United States
and is the leading cause of death (CDC, 2021). Etiology of prostate cancer remains unclear but in
recent research it has been shown that there is an association between occupation and prostate
cancer risk (Sritharan, et al., 2019). Specifically protective service occupations including
firefighters, policeman and detectives, guards, and watchmen (Sritharan et al., 2019).
Significance: With new evidence of risk factors, it is important that these individuals understand
that they are at an increased risk of being diagnosed with prostate cancer. In 2018, New York
State reported 15,714 cases of prostate cancer. With such a high incidence it is important that
these individuals are participating in secondary prevention measures in the hopes that prostate
cancer is caught early.
PICOT Question: This EBP proposal is framed around the following PICOT question:
Among persons who are in protective service occupations, what is the impact of a Nurse
Practitioner led shared decision coaching program that utilizes a decision aid on improved
knowledge of prostate cancer, confidence in shared decision making for prostate cancer
screening and patient satisfaction over 12 weeks?
Clinical Change: The change that will be implemented in this proposal is a nurse practitioner
led shared decision coaching that will occur in a primary care setting with participants in
protective service occupations. Education will be provided during the decision coaching and an
opportunity to ask questions about prostate cancer and an individual’s specific risk factors will
be allotted. Following the decision coaching the patient will be given the choice to have a PSA
test ordered for them and if they decide to follow through with PSA testing, the nursing staff
with take their blood draw then.
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Desired Outcome: The desired outcome of this evidence-based proposal will include improved
knowledge of prostate cancer specifically anatomy and function, risk factors, screening, and
symptoms of prostate cancer. Other outcomes include increase in PSA testing with improved
confidence in decision making regarding the testing and improved satisfaction with the
interaction between the patient and nurse practitioner.
Summary: Through a review and synthesis of the literature, it was determined that the use of
decision coaching and the use of decision aids are effective interventions for improving
knowledge, satisfaction, and confidence.

Keywords: prostate cancer, PSA testing, protective service occupations, shared decision making,
informed decision making
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An Evidence-Based Proposal Supporting Prostate Specific Antigen in Protective Service
Occupations
Prostate cancer is the most common cancer among men in the United States and is one of
the leading causes of cancer death in men of all races (CDC, 2021). The latest incidence data
from the Centers for Disease Control and Prevention is from 2018. In 2018, it was noted that in
the United States there was 211,893 new cases of prostate cancer reported, and 31,488 men died
from prostate cancer (CDC, 2021). For every 100,00 men, 108 new prostate cancer cases were
reported, and 31 men passed away (CDC, 2021). In New York state specifically, the age adjusted
rate of new cases were 132.4 per 100,000 (CDC, 2021). New York State had a total of 15,714
cases reported that year.
The etiology, also known as the cause of prostate cancer, remains unclear but the most
well-established risk factors include age, family history of prostate cancer, and ethnicity
(Sritharan et al., 2018). Other risk factors potentially contributing to higher rates of prostate
cancer include diet, obesity, smoking, sexual behavior, sexually transmitted disease, genetic
mutations, hormone levels, and occupation (Sritharan et al., 2018). Men older than the age of 50
and of African American ethnicity, as well as men who have a family history of the cancer, are at
an increased risk of prostate cancer and are more likely to seek out secondary prevention
measures (Sritharan et al., 2019). Recent studies completed in Canada examined work-related
risk factors for prostate cancer and have shown an association between employment and prostate
cancer risk (Sritharan, et al., 2019). The occupations at higher risk for prostate cancer include
management and administration, farming, construction, transportation, and protective service
occupations including firefighters, policeman and detectives, guards, and watchmen (Sritharan et
al., 2019). The results of Sritharan et al. (2019), suggest that night shift work is associated with
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prostate cancer and that those are frequent hours that protective service occupations work.
Significant elevated risks were observed across protective services occupations for firefighters
and police officers but there was no observed significant increased risk for armed forces and
other protective services (Sritharan et al, 2018). The logic surrounding the increased risk of
prostate cancer in protective services occupations involves increased exposure to diesel exhaust,
dust and particulate matter, chemical agents, and radiation (Sritharan et al., 2018). Many
overnight protective service occupations may also have a disruption in their circadian rhythm
due to the hours of work (Sritharan et al., 2019). Protective service occupations can also be under
constant psychological stress which may impact biological processes leading to the development
of cancer (Sritharan et al., 2018). Even though the etiology remains unclear on prostate cancer,
there is an obvious and documented correlation between prostate cancer and protective service
occupations.
Because it is known that persons in service occupations have a higher risk of prostate
cancer occurrence, it is important to implement prevention strategies in this population. Primary
prevention and early intervention for prostate cancer may include measures such as diet and
lifestyle modification and education programs promoting healthy living and early screening.
Secondary prevention measures are screenings to identify disease in the earliest stages,
before the onset of signs and symptoms of a disease, examples include mammography and
regular blood pressure testing (Prevention, n.d.). Secondary prevention measures are also
important to managing prostate cancer cases. Secondary prevention includes screening for
prostate cancer using the Prostate Specific Antigen (PSA) test and digital rectal exams (DRE).
The PSA is a blood test that measures the level of PSA in the blood (CDC, 2021). Prostate
Specific Antigen is a substance made by the prostate that can be elevated in individuals who
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have prostate cancer as well as in persons with other conditions that affect the prostate such as an
enlarged prostate, prostate infection, certain medical procedures, and certain medications (CDC,
2021). A normal PSA level is between 1-1.5 ng/ml. An above normal PSA level in the blood
tends to a greater likelihood that a prostate problem is present (CDC, 2021). There are many
factors that can affect the PSA level including an increased age and African American race.
Another secondary prevention measure is a Digital Rectal Examination (DRE). The DRE is
when a health care provider inserts a gloved lubricated finger into a man’s rectum to feel the
prostate for anything abnormal such as a tumor (CDC, 2021). A DRE is not currently
recommended by the U.S. Preventative Services Task Force (USPSTF) as a screening test
because of the lack of evidence on the benefits (CDC, 2021).
Many facilities and providers respect the USPSTF recommendations when it comes to
cancer screening recommendations. The USPSTF is an independent, volunteer panel of national
experts in prevention and evidence-based medicine that works to improve the health of people
nationwide by making evidence-based recommendations about clinical preventive services such
as screenings, counseling services, and preventive medications (U.S. Preventative Service Task
Force, n.d.). The USPSTF uses a grading scale (Grade A, B, C, D, and I) to determine the
suggestions of practice. The USPSTF recommendation for prostate cancer screening for men
between the ages of 55 through 69 is a Grade C (U.S. Preventative Service Task Force, 2018).
The Grade C prostate cancer recommendation includes that the decision to undergo periodic PSA
based screening for prostate cancer should be an individual one (U.S. Preventative Service Task
Force, 2018). Providers and patients should consider the balance of benefits and harms based on
family history, race/ethnicity, comorbid medical conditions, patient values about the benefits and
harms of screening and treatment specific outcomes and other health needs (U.S. Preventative
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Service Task Force, 2018). Clinical decisions about PSA testing involve more considerations
than evidence alone and should be individualized with each patient (Jama, 2018). Before one
decides to proceed or not with the PSA test, one should have the opportunity to discuss the
potential benefits and harms of screening with their provider and should incorporate their values
and preferences in the decision (U.S. Preventative Service Task Force, 2018).
There is an uncertainty that is associated with PSA testing and the USPSTF recommends
a discussion occur between the patient and provider about the risks and benefits of PSA testing.
This can be called shared decision making (SDM) between patient and provider. Since the
introduction of SDM, decision-making studies have shown that the patient-provider
conversations are not occurring (Hopper, et al., 2017). In Hopper et al. (2017), the authors
explored the barriers to prostate cancer screening and identified that there was a variation in
patient-provider communication. Several participants felt that appointments with their providers
were rushed or too short leading to the patient coming prepared the next time with notes on
questions to ask (Hopper et al., 2017). Others felt that their provider never discussed prostate
cancer screening with them or when discussed, they did not give them enough time to make an
informed decision about the screening (Hopper et al., 2017). Participants also expressed the
need for more information about prostate cancer symptoms, risks for developing prostate cancer,
prostate cancer screening, and information about follow up for repeat PSA testing (Hopper et al.,
2017). This research has shown that some individuals are not engaging in SDM with their
provider. It would be beneficial to both the patient and the provider if SDM occurred with the
use of a decision aid to help provide better education on prostate cancer and give individuals the
knowledge and time to make an informed decision.
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Definition of Terms
During this evidence-based proposal the reader may come across some terms that they
are not familiar with. These are terms will be used frequently in this proposal.


Protective Service Occupation: Firemen both volunteer and paid, investigators,
police officers and detectives.



Motivational Interviewing: An interviewing technique that allows for a genuine
conversation to occur between the patient and nurse practitioner.



Shared Decision Making: A patient deciding with the nurse practitioner on their
specific risks and benefits of going through with PSA testing.



Decision Aid: A tool that provides education about prostate cancer which aids in
increasing knowledge.



Informed Decision Making: A patient has all the information and education on
risks and benefits of PSA testing that will lead to them making the nest decision
for themselves.
Identification of Problem

The literature supports prostate cancer is one of the most common cancers without clear
etiology. It is known that prostate cancer is more common in African American men, in
individuals with a family history of prostate cancer and in those over the age of 65. The literature
also supports those occupational hazards are common to specific occupations such as protective
service occupations. This occupation can increase the risk of being diagnosed with prostate
cancer. The USPSTF recommends PSA screening in individuals at risk for being diagnosed with
prostate cancer. It is important for individuals to be informed properly and to not make decisions
on PSA testing when the risks and benefits of testing are not clearly understood. Even with the
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USPSTF recommendations being published regarding prostate cancer screening, an increase in
communication and SDM between providers and patients has not been experienced (U.S.
Preventative Service Task Force, 2018). With the absence of conversations and SDM, there is a
risk that those who are at increased risk of prostate cancer will not be screened and will not
receive proper recommended PSA testing.
Significance of the Clinical Problem
Protective service occupations, whether it be fireman, policemen, or detectives, have an
increased risk of being diagnosed with prostate cancer (Sritharan et al, 2018). With proper cancer
screening in individuals who do have a greater risk of being diagnosed with prostate cancer, an
earlier diagnosis may lead to improved outcomes. With 31,488 deaths in the United States in
2018, there is no doubt that prostate cancer is prevalent. Engaging high risk patients in SDM and
informed decision making will increase knowledge of the risks, and benefits to screening for
prostate cancer. Early screening has the potential to increase survival rate with earlier detection
and less invasive treatment options.
EBP Proposal Purpose
The purpose of this EBP proposal is to improve knowledge on prostate cancer, ensure
that there is a productive engagement of shared decision making between the nurse practitioner
and those in the protective service occupations and improve the patient’s confidence in their
decision regarding PSA screening. The process of SDM, increased risk communication and the
use of the decision aid is intended to increase overall patient satisfaction including satisfaction
with communication between patient and nurse practitioner.
PICOT Question
This EBP proposal is framed around the following PICOT question:
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Among persons who are in protective service occupations, what is the impact of a Nurse
Practitioner led shared decision coaching program that utilizes a decision aid on
improved knowledge of prostate cancer, confidence in shared decision making for
prostate cancer screening and patient satisfaction over 12 weeks?
Summary
Chapter one has presented data on the prostate cancer prevalence, etiology, and primary
and secondary prevention measures as well as screening using the PSA and DRE. Presented were
the USPSTF recommendations for prostate cancer screening and the use of shared decision
making. It is known that prostate cancer is seen more frequently in protective service
occupations such as firefighters and police officers. It is of prime importance that interventions
include the use of SDM in the protective service occupation employee that includes coordination
with the NP who can guide the patient toward EBP education and screening. Chapter two will
provide a review of the literature and presentation of the evidence to support a change in prostate
screening using SDM in protective service occupations.
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Chapter Two: Synthesis of the Evidence
A thorough search of the literature was conducted to gather support for this evidencebased proposal. The three main themes that emerged from the literature are: 1) Shared Decision
Making (SDM) between the Nurse Practitioner and the patient 2) Community Health Workers
and Motivational Interviewing and 3) The use of a decision aid to provide better education to the
patient. A comparison will be drawn between the role of the nurse practitioners as a community
health worker or health coach in the decision-making process for prostate cancer screening. A
synthesis of the literature will be presented in this chapter.
Search Strategies
Various search strategies and databases were used to gather quality research and literature
to the relevant topic that is discussed in this evidence-based proposal. The main databases used
were MEDLINE with full text and CINAHL. Access to full-text articles were obtained via the
Daemen College Library website. Keywords that were used to search for appropriate literature
included “shared decision making”, “prostate cancer”, “community health coaching”,
“motivational interviewing”, and “decision aid”. All articles were derived from scholarly and
peer-reviewed sources and have been published with the last five years (2016 to 2021) except for
two articles that were published in 2015 and 2012. Articles were chosen based on the relation to
prostate cancer, secondary prevention measures, community health workers and decision aids.
Articles did not need to include all the criteria listed above. The level of evidence in this
literature review is primarily level I. Ten out of the fifteen articles are level I. Level I articles are
experimental studies, randomized controlled trials (RCT), and systemic reviews of RCT with or
without meta-analysis. Two out of the fifteen articles used level II evidence, this included quasiexperimental study, systemic review of a combination of RCTs and quasi-experimental studies
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only, with or without meta-analysis. Three out of the fifteen articles were level V. Level V
evidence includes literature reviews. Refer to appendix A for a matrix review of the literature.
Synthesis of the Evidence
Theme One: Shared Decision-Making
The first theme that emerged from the literature was the importance of shared decision
making between the nurse practitioner (NP) and the patient. This theme was prevalent in two
studies completed by Stamm et al. (2017), and Makarov et al. (2021). As explained in chapter
one, it is important to understand that the decision on whether to screen for prostate cancer or not
is the patient’s choice. At the same time as the choice for screening is the patient’s, the role of
the NP to assist the patient with understanding his risk of developing prostate cancer, the
benefits, and risks of testing so that an informed decision can be made.
The purpose of the Stamm et al. (2017), study was to evaluate whether the use of a
decision aid with or without shared decision making during a primary care visit influenced
knowledge of prostate cancer screening and rates of PSA-based prostate cancer screening. The
results were identified by stratifying outcomes by short term provider relationship (STPR) and
long-term provider relationship (LTPR). Stamm et al. (2017), stated that shared decision making
(SDM) in prostate cancer screening should have three components: The patient must have a
defined choice; the patient must be apprised of his options; and lastly, the decision must ensue
based upon the patient’s values, preferences, and provider guidance. Stamm et al. (2017),
discussed that the patients who had a decision aid along with SDM were significantly more
likely to report the possibility of a diagnostic procedure or surgery compared to those who
received usual care. Participants who received a decision aid alone were significantly less likely
to report that they always felt encouraged to discuss all health concerns. The overall results of
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the study showed that the use of a decision aid alone is an inadequate substitute for a direct
conversation between patients and providers through SDM.
Makarov et al. (2021), discussed the use of community health workers (CHW) and
decision coaching to promote SDM for prostate cancer screening. The purpose of the study is to
evaluate the efficacy of a community health worker led decision-coaching program to facilitate
SDM for prostate cancer screening among black men in the primary care setting. It is known that
CHW-led interventions improve awareness, knowledge, support, and efficacy to reduce the
impact of chronic disease and cancer in underserved populations (Makarov, et al., 2021). With
this knowledge it seems that CHW’s are ideally suited to help primary care practices seeking to
facilitate SDM for PSA screening. This study is currently ongoing with an anticipated
completion in March of 2023. The anticipated result of the study is that the use of a CHW led
decision coaching will improve or optimize decision quality regarding prostate cancer screening.
Theme Two: Community Health Worker and Motivational Interviewing
The second theme that emerged from the literature was that CHW’s and motivational
interviewing (MI) improved behavior and knowledge or education on disease processes. The
theme was prevalent in many of the articles that were reviewed (Alaofè, et al., 2017; AlizadehSabeg , et al., 2021; Brandford et al., 2018; Kim et al., 2016; Makarov et al., 2021; Palmas, et al.,
2015; Portillo, Vasquez & Brown 2020; Stacey, et al., 2012; Roland et al, 2017). Kim et al.
(2016), conducted a review of studies that looked at the impact of community-based health
workers (CBHW). Most studies focused on preventing cancer and cardiovascular disease. The
tasks that were carried out in these studies included providing education and counseling, helping
patients navigate the health care system, managing care, and providing social services and
support when needed. The interventions completed by CBHW were performed in collaboration
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with other health care professionals such as primary care providers. In total, 30 studies tested the
effect of CBHW-led intervention on cancer control, 21 of the studies (70%) found improvements
in cancer screening behaviors. The CBHW builds trust and rapport and can communicate with
the community; thus, explaining why CBHWs play an important role in patient-center care
teams.
Similarly, Roland et al. (2017), identified 24 articles that all reported positive outcomes
of CHW interventions within federally qualified health centers. According to Roland et al.
(2017), the CHW's efforts have led to an increase in cancer screening and timely completion of
diagnostic follow-up and cancer treatment initiation.
Makarov et al. (2021), is an ongoing study that proposed that a CHW-led decision
coaching program facilitates SDM for prostate cancer screening discussions in black men in a
primary care setting. The anticipated outcome of the study that there will be an increase in PSA
screening. There will also be improvement and optimized decision quality. Another outcome that
is anticipated is that there will be improved behaviors and norms surrounding PSA screening.
For the last 19 years Americans have rated the honesty and ethics of nurses highest
among a list of professions that Gallop asked the U.S. adults to assess annually (Reinhart, 2020).
In 2020, 85% of Americans stated nurses’ honesty and ethical standards are “very high” or
“high” (Reinhart, 2020). The American Association of Nurse Practitioners (2019) explained that
seeing a nurse practitioner for care has been tied to having higher rates of satisfaction, more
health counseling added focus on prevention, improved communication, greater follow up, fewer
emergency room visits, and more time spent with patients. All NP’s start off their career as
registered nurses (RN) and may progress to become NPs. Many qualities such as honesty and
ethics remain as core values in NPs from their time spent as RNs. It can be assumed that higher
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rates of satisfaction and improved communication with NPs can be attributed to the time spent in
the role of an RN, trust built in the NP who function as an RN, improved communication skills,
increased follow-up and increased time spent with patients. Nurse practitioners can make great
health coaches who can help move patients to decision making.
Alizadeh-Sabeg et al. (2021), used a randomized control trial to study the effect of
motivational interviewing (MI) on the change in breast cancer screening behaviors. Motivational
interviewing is considered a client-centered approach, aimed at improving the motivation of
clients to change their behavior over time. The results of the Alizadeh-Sabeg et al. (2021), study
showed that MI-based counseling increased women’s motivation for displaying breast cancer
screening behaviors. Before the MI-based counseling, participants were in the contemplation
stage but after the intervention (MI-based counseling sessions) most participants entered the
action stage for self-breast checking and clinical breast examination.
Stacey et al. (2012), is an older article but serves to provide adequate information in
decision coaching. In this systemic review, Stacy et al. (2012), explored characteristics and
effectiveness of decision coaching evaluated within trials of patient decision aids (PtDAs) for
health decisions. Decision coaching used with PtDAs compared to usual care showed an
improvement in knowledge and participation in decision making without any report of
dissatisfaction. It was also mentioned that decision coaching by someone within the health care
team is one strategy for ensuring relevant PtDAs are subsequently discussed with the patients.
The NP functioning in the role of a decision coach in the health care team can ensure relevant
information regarding prostate cancer will be discussed with patients in this EBP.
Palmas et al. (2015), reviewed the efficacy of CHW intervention to improve glycemia in
people with diabetes as opposed to usual care. The interventions included education provided by
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a diabetes educator, being managed by a diabetes nurse, or receiving a 6-month diabetes selfmanagement education program. Those were received a 6-month diabetes self-management
education program later Articles that were reviewed compared the use of a CHW such as a
diabetes educator to the usual care that they would receive. The meta-analysis suggested the use
of CHW lasting at least 12 months resulted in a modest reduction of hemoglobin Alc compared
to usual care. It was also discussed that studies that have a more visit intensive CHW protocol
might have had greater efficacy. Similarly, Alaofè et al. (2017), discussed diabetes prevention
and management with the use of CHW interventions. These interventions included providing
nutritional education and established appropriate daily exercise activities for 3 months. Ten
studies were reviewed, and seven of the ten positive outcomes were observed. These positive
outcomes included increased knowledge of type 2 diabetes mellitus symptoms and prevention
measures; increased adoption or treatment-seeking and prevention measures; increased
medication adherence; and improved fasting blood sugar, glycated hemoglobin, and body mass
index. Both articles used community health workers and interventions that improved health
promotion behavior and showed a reduction in Hemoglobin Alc. The use of CHWs can improve
knowledge of prostate cancer and potentially improve confidence in shared decision making for
prostate cancer screening and patient satisfaction. Nurse practitioners taking on the role of CHW
would positively effect teaching because they have the knowledge of prostate cancer, diagnostic
procedures, and secondary prevention measures. They would also be able to answer questions
that the participants may have during the session.
Portillo, Vasquez, and Brown (2020), explained that MI is a client-centered technique
intended to bring awareness to risky behaviors and increase the chances that the person will
change their behavior. It was shown that MI adherence by CHWs improves over time and is
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achievable. Nurse Practitioners, by their training, are adept with MI techniques. Portillo et al.
(2020), discussed the CHWs serving as a bridge between the community and health-care
professionals due to their ability to empathize with participants. Lastly, Branford et al. (2019),
described the feasibility of training CHWs to deliver MI to promote cancer screening in
underserved populations. The article concluded that one of the most powerful strategies to
address cancer disparities in the use of CHWs to influence behavior surrounding cancer
screening. When CHWs were trained to use MI, the CHWs felt that it was feasible and valuable
to the work of promoting cancer screening in underserved populations (Branford et al., 2019).
The behavior change desired in this EBP would be improved knowledge of prostate
cancer, confidence in SDM for prostate cancer screening and patient satisfaction. As nurses and
NPs are one of the most trusted professions, the NP has an ability to empathize with patients
making them an ideal CHWs or decision coaches. Implementing the NP as a decision coach who
uses SDM and MI strategies in protective service occupations who are at greater risk for
developing prostate cancer may improve adherence to prostate cancer screening.
Theme Three: The Use of a Decision Aid
Lastly, the third theme that was established from the matrix was the use of a decision aid
to help the nurse practitioner in engaging in SDM (Allen, Filson, & Berry, 2020; Allen, et al.,
2019; Owens, et al., 2018; Owens, Wooten, & Tavakoli, 2019; Rim, et al., 2018; Stacey, et al.,
2012). Decision aids are patient based tools developed to help patients make medical decision
about their healthcare (O’Conner, et al., 2009). Approximately half of the articles reviewed
discussed the effective use of a decision aid.
Owens et al. (2018), explained that informed decision making (IDM) is characterized by
a patient having a clear understanding about the disease, possessing knowledge of the risks,
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benefits, and uncertainties of screening and subsequent treatment, and actively engaging at the
level of decision-making desired. The decision aid that Owens et al. (2018), specifically used
was iDecide, which is an embodied conversational agent-led, computer-based prostate cancer
screening decision aid. The use of iDecide increased knowledge of prostate cancer as well as
vastly improving informed decision-making self-efficacy. Over half of the men that participated
in the study reported that they intend to participate in IDM with their healthcare provider within
the next six months.
Rim et al. (2018), examined current primary care providers’ perspectives on the use of
decision aids (DA) and explored whether providers’ beliefs and interest in use of a DA was
associated with offering PSA tests for early detection of prostate cancer. It was explained that
DAs are tools intended to help people weigh the benefits and harms of a health decision. In one
controlled trial conducted, the authors found that providing patients a DA without a personal
conversation and clinical encounter resulted in greater likelihood of a patients having a PSA test
without improved knowledge of the test or the potential benefits and harms of their decision.
This is then defeating the purpose of a DA. When a NP has receptivity towards tools or Das, they
can assist in and supplement conversations about PSA testing. Currently only 11% of providers
use a DAs when discussing PSA testing with patients while 54% of providers currently do not
use DAs but are interested in learning about incorporating a DA into their practice (Rim, et al.,
2018).
Allen, Filson, & Berry, (2020) piloted an online DA in primary care settings. The goal
was to determine the impact of an online DA on patients’ ability to engage in SDM about
prostate cancer screening. Barriers were identified that deterred fully engaging patients in SDM
such as the short duration of medical appointments and the need to prioritize a range of health
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concerns. Allen, Filson, & Berry (2020), completed a meta-analysis and systemic reviews that
demonstrated that DAs can effectively increase patients’ knowledge about prostate cancer
screening, promote confidence in the ability to engage in decision-making with one’s provider
and decrease decisional conflict. One goal of this EBP is to promote confidence in shared
decision making, this article shows that a DA can increase one’s confidence. The online DA that
was developed for the Allen et al. (2020) study, provided men with the knowledge and skills to
participate in SDM about PSA testing with their providers. At completion of this study the mean
average of individuals who felt that the DA prepared them “very well/well” for the conversation
about SDM with their provider were 89.5%.
Owens, Wooten, & Tavakoli, (2019) evaluated the use of psychometric properties of
computer based prostate cancer screening DAs. The article discussed that for African American
men to make informed decisions they need prostate cancer knowledge to be explained in plain
language. It was shown that self-efficacy, computer anxiety and attitude towards technology did
not correlate with technology acceptance or use. The article determined that the computer-based
decision aid acceptance scale showed potential as playing a key role in increasing prostate cancer
knowledge and assisting in informed decision making among African American men. One can
conclude from the literature that the use of a DA can increase knowledge and decision making.
Allen et al. (2019), explained that many national studies show that many patients do not
experience SDM in the context of prostate cancer screenings. Shared decision making is often
difficult to accomplish in clinical practice due to the short duration of clinical visits, the need to
address competing health priorities and communication challenges between patients and
providers (Allen et al., 2019). Decision aids are promising means to prepare men to engage in
SDM that can often occur prior to the appointment. Principle findings showed that DAs are an
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effective intervention to complement patient/provider engagement in SDM by providing patients
with information needed to assess their options and examine their values (Allen et al., 2019).
Stacey et al. (2012), explored the characteristics and effectiveness of decision coaching
and the use of patient DAs. Decision coaching along with the use of a DA shows improvement in
knowledge and participation in decision making without reported dissatisfaction. Two trials that
used both decision coaching and a DA showed improved patient knowledge and treatment
options for individuals with schizophrenia and women considering breast cancer genetic testing.
Articles that also used coaching along with DAs compared to usual care had higher perceived
participation in decision making. The use of a DA and decision coaching can improve both
knowledge and participation in the decision-making process (Stacey et al., 2012). This is useful
information seeing that this EBP is measuring both improved knowledge and confidence is
decision making.
Synthesis of the Whole

The review of literature that has been completed for this evidence-based proposal
provides great evidence to support the use of a decision aid with a community health worker or
health coach improves knowledge, satisfaction, and confidence. The three themes identified in
the research positively influence the PICOT question. The articles that were reviewed for this
proposal touched base on more than one option to improve knowledge, satisfaction, or
confidence. Community health workers or health coaching and motivational interviewing have
also shown to improve knowledge and communication (Alizadeh-Sabeg et al., 2021; Brandford
et al., 2018; Portillo, Vasquez & Brown, 2020). Roland et al., 2017 recognized that community
health workers lead to positive outcomes related to completion of cancer screenings (RR = 1.35,
95% CI: 0.95–1.92). A nurse practitioner would make an ideal community health worker or
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health coach because they hold trust with the community. Generally, nurse practitioners spend
more quality time with patients and patients feel that nurse practitioners listen to their concerns.
These feelings and relationships that the patients have towards the nurse practitioners can
improve satisfaction.
Research has proven that the use of a decision aid will improve knowledge and leads to
better communication and improvement in SDM (Allen et al., 2019; Allen, Filson & Berry,
2020; Owens et al., 2018; Owens, Wooten & Tavakoli, 2019). The use of a decision aid can also
lead to better informed decisions regarding PSA screening (Allen er al., 2019). This is important
because informed decisions lead to an improvement in confidence in decision Stamm et al., 2017
proved that there are better outcomes when shared decision making and a decision aid are used
together when compared to usual care (72% DA, 78% DA + SDM, 87% UC, p = 0.0285). Stacey
et al. (2012), was one specific article that compared the use of a decision aid alone, the use of
community health worker alone, as well as the combination of both the decision aid and usual
care. The use of a decision aid and community health worker working together improved
knowledge (15.0 v. 10.9; P = 0.01), participation (COMRADE 79.5 v. 69.7; P = 0.03), and
satisfaction (odds ratio 1.49; 95% confidence interval, 1.11–2.01; P = 0.008) compared to usual
care. This evidence showed that the use of both a decision aid and community health worker
will meet all the requirements that were identified in the PICOT question. Unfortunately, there
has not been a significant amount of research done supporting the use of SDM, DAs and CHWs
regarding prostate cancer and protective service occupations. This evidence-based proposal will
provide more information regarding individuals in protective service occupations at risk of
prostate cancer and the use of a decision aid, community health workers (the NP for the purposes
of this EBP) and shared decision making.
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Proposed Clinical Change
A thorough analysis and review of literature was completed. It was determined that the
combination of a decision aid and community health worker, such as a nurse practitioner are both
appropriate and successful methods to improve knowledge of prostate cancer, confidence in
shared decision making for prostate cancer screening and patient satisfaction. Research has
shown that individuals in protective service occupations have an increased risk of being
diagnosed with prostate cancer. Research has also proven that with the change that the USPSTF
completed regarding PSA and the decision to test for PSA being put directly on the patient there
have been less providers participating in shared decision making.
In this EBP we will determine the impact that a Nurse Practitioner led decision coaching
program will have on individuals who are in protective service occupations such as improved
knowledge on prostate cancer, increased confidence in decision making and improved
satisfaction. The goal of the nurse practitioner led decision coaching using a DA will be to
improve knowledge of prostate cancer, confidence in shared decision making for prostate cancer
screening and patient satisfaction. Knowledge of prostate cancer, confidence in shared decision
making for prostate cancer screening and patient satisfaction will be completed during the
decision coaching session and the decision aid that will be given out in the waiting room while
the patient waits for the decision coaching to begin. During the decision coaching session, the
nurse practitioner will educate on where the prostate is located, what prostate cancer is, risk
factors, signs and symptoms of prostate cancer, secondary prevention measures and the risks of
the PSA testing. The nurse practitioner will also review the patients specific risk factors. During
this session the patient will be allotted time to ask about questions or concerns about anything
they learned about prostate cancer, PSA testing or any other questions they have regarding their
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health related to their prostate. At the completion of the decision coaching session the patient
will be asked if they would like to proceed with PSA testing.
Summary
A synthesis of evidence provides an inclusive summary of the findings from the
literature. Three distinctive themes emerged that demonstrate the value of DAs to improve
knowledge. The use of health coaching and motivational interviewing improves knowledge and
communication. In chapter one it was discussed that the USPSTF recommended SDM regarding
PSA testing and the literature did show that SDM provided better results in communication. As
this evidence-based proposal moves forward further detail will be provided concerning guidance
for implementation of the intervention and well as the various factors that will facilitate and
impact the change.
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Chapter Three: Framework
To support and strengthen this evidence-based proposal, a nursing theoretical framework
and EBP model will be used. The nursing theory chosen to guide the proposal is the Health
Promotion Model (Pender, 1982). The EBP model that will be applied is the Stetler Model
(1976). The Stetler Model will guide the research methods and plan for implementation of this
research. Both the framework and EBP model will be used congruently in this research proposal.
Theoretical Framework
Nola Pender developed the Health Promotion Model in 1982, which was later revised in
1996 (Sitzman & Eichelberger, 2017). Pender’s Health Promotion Model is a high middle-range
theory. Pender’s Health Promotion Model believed that professionals intervened only after
people developed an acute or chronic disease and experienced compromised lives (Sitzman &
Eichelberger, 2017). Pender felt that this was not a proactive stance on health promotion and
disease prevention (Sitzman & Eichelberger, 2017). Health professionals have multiple
opportunities to encourage health-promoting behaviors related to presenting concerns and
anticipated health challenges (Sitzman & Eichelberger, 2017). When using Pender's Health
Promotion Model regarding this proposal it is using the idea that health professionals such as
nurses or nurse practitioners are an important tool for educating males in protective service
occupations positions on improved knowledge of prostate cancer, confidence in shared decision
making for prostate cancer screening and patient satisfaction.
Pender’s Health Promotion Model is simple to understand. It begins with an assessment
by a healthcare professional, specifically gathering data related to behavior, personal factors,
patient perceptions, and competing demands (Sitzman & Eichelberger, 2017). Then it shifts to
planning the healthcare professional and the patient will work together to develop a health
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promotion plan and the patient commits to the plan of action (Sitzman & Eichelberger, 2017).
The implementation is the incorporation of health-promoting behavior (Sitzman & Eichelberger,
2017). Lastly, this will be evaluated based on the actual incorporation of health-promoting
behavior (Sitzman & Eichelberger, 2017).
EBP Model
The EBP Model chosen for this proposal is Stetler Model (1976), this model follows the
concept of research utilization (RU) (Stetler, 2001). The Stetler Model was developed in 1976
but later updated in 1994 to reflects a practitioner-oriented approach (Stetler, 2001). There are
five phases of the Stetler Model, these phases will provide guidance for this proposal. The phases
are preparation (Phase I) , validation (Phase II), comparative evaluation/decision making (Phase
III), translation/application (Phase IV) and evaluation (Phase V). The Stetler Model provides a
clear set of guidelines that are designed to overcome potential barriers to the utilization and
integration of evidence (Stetler, 2001).
Application of Framework to EBP Proposal
The Health Promotion Model (Penders, 1982), along with the phases of the Stetler Model
(1976) can both be readily applied to this evidence-based proposal. In summary, Pender
identified multiple factors that would have a potential influence on an individual's healthpromoting behaviors. One factor that correlates with this research is interpersonal influences.
Interpersonal influences are how significant others around the participant or patient affect
motivation for positive change (Sitzman & Eichelberger, 2017). In this proposal, the significant
other is the nurse practitioner. At the end of the research study, the nurse practitioner and the
patient will be able to identify if the use of a decision aid enhanced knowledge of prostate cancer
and promoted SDM regarding PSA testing and informed decision making. This will lead to nurse
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practitioners identifying if the decision aid enhanced education and promoted informed decision
making with SDM.
In this proposal, we will be assessing the patient’s knowledge of prostate cancer,
confidence in shared decision making for prostate cancer screening and patient satisfaction. The
nurse practitioner will develop a nurse practitioner led decision coaching program to educate on
prostate cancer knowledge, secondary prevention measures that enhances informed decision
making with the use of SDM. We will evaluate that knowledge was increased and that
confidence in decision making and satisfaction with the communication between the nurse
practitioner and patients was accomplished.
The Stetler Model (1976) will be applied to this evidence-based proposal by following
the phases in correct order. Phase I, which is Preparation, is to identify a priority need. This
phase been completed when the purpose of the Evidence-based proposal was identified. The
purpose was identified in the PICOT question and purpose statement. This information can be
found in Chapter One. Phase II, which is Validation, can be found in Chapter Two as well as
appendix A. Phase II assess sources of evidence for the level and overall quality of the research
completed. It is looking to see if the articles have merit and goodness of fit in relation to the
purpose of the project. A review of literature was conducted to review the relevance of the
evidence and a matrix was built to assess the quantity and quality of the evidence. Phase III,
which is Comparative Evaluation/Decision Making, involves summarizing the similarities and
differences among the sources of evidence that are evaluated. This will then determine if it is
acceptable and feasible to apply the finding to practice. This again has been completed in
Chapter Two, through an extensive synthesis of the evidence and planning for implementation of
the proposed intervention. Phase IV, Translation/Application, this phase is the development of
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how to implement the summarized findings and identify practice implications that justify
application of findings for change (Stetler, 2001). This was identified in Chapter Two in the
description of the strategy for the proposed change. Phase V, Evaluation, which is the final
phase. This is the identification of expected outcomes of the project and the determination
whether the goals of the Evidence-Based Proposal were successfully achieved (Stetler, 2001).
The evaluation can be formal or informal, as well as individual or institutional (Stetler, 2001). It
is important to consider cost-benefit of various evaluation efforts and to use research utilization
as a process to enhance credibility of evaluation data (Stetler, 2001). This phase will be
discussed in the succeeding chapter, and it will include identification of stakeholders, budgeting
and cost propositions and proposed plan for implementation.
Congruence of Framework to EBP Proposal
The theoretical framework and the EBP model are congruent with the topic of this
proposal. The Health Promotion Model (1982) coincides with the proposed clinical change due
to the idea that health care providers only intervened after an acute or chronic problem occurred.
It places emphasis that health care providers need to be proactive and encourage healthpromoting behaviors such as secondary prevention measures like PSA testing.
The Stetler Model (1976) is congruent with this proposal due to its systematic, step by
step approach to Evidence-Based Proposals. It outlines the necessary steps for the proposal of an
evidence based clinical change. This occurs by identifying a clinical problem (Phase I), to
devising a plan for implementation (Phase IV). In the next chapter there will be a more specific
outline of the Stetler Model (1976) that is specific to this Evidence-Based Proposal.
Setting
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The setting in which the proposed nurse practitioner led decision coaching program will
take place is a primary care office that is in proximity of multiple firehalls and police stations.
This office is in the city Buffalo, New York and serves many male patients that are employed in
protective service occupations. The clinicians in this office are two physicians, six primary care
nurse practitioners and one physician assistant. The population that is primarily served at this
office is individuals older than 18 years old to end of life. There is a total of nine healthcare
providers in this office along with many other healthcare professionals such as registered nurses
and licensed practical nurses. The registered nurses and licensed practical nurses complete all
laboratory draws that the physicians and nurse practitioners order at that current visit. Without
leaving the building patients also have access to a walk-in clinic and a pharmacy. The office is
located near many fire halls, police stations and the district attorney office that employ many
detectives. The facility serves many protective service occupations. This office does have
another location located in another section of the city.
Population
The population of interest for the proposed clinical change comprises those in protective
service occupations in an outpatient setting. These individuals will all be male and should be
over 40 years old but no older than 69 years of age. The population can be easily assessed at
local police stations, volunteer or paid fire halls or the district attorney’s office which employ
investigators which is near to the primary care office indicated in our setting.
System Focus
It is important to consider all the integral parts of the system that may affect the process
of the proposed clinical change, or that may be affected by the proposed clinical change. A
system focus will consider the factors that may be affected by this clinical change. We will

34
examine the small (micro) and large (macro) scale effects that may be impacted by the clinical
change. Many factors both internal and external play a role in the impact of the proposed clinical
change.
Micro/Macro Focus
When looking at the system with a microfocus lens, we are looking for smaller-scale
details or components involved. Regarding the proposed clinical change of a Nurse Practitioner
led shared decision coaching program that utilizes a decision aid on improved knowledge of
prostate cancer, confidence in shared decision making for prostate cancer screening and patient
satisfaction, there are many relationships that effect this category. When looking through a micro
lens the primary relationship to consider is the levels of healthcare delivery. The levels of
healthcare delivery include the patient and the care team. It is important to think about how the
proposed clinical change will affect this relationship between the patient and the provider.
Clinical changes that will occur include educational transaction which will include prostate
cancer education and PSA testing. Effective teaching with the use of a decision aid will need to
transpire to improve confidence in shared decision making and patient satisfaction. Another
clinical change that will occur will be the conversation between the nurse practitioner and patient
regarding shared decision making about secondary prevention measures such as PSA testing.
This will transpire during the nurse practitioner shared decision coaching program. The patient’s
family can be involved during this process if the patient would like them to participate in the
shared decision process with them.
When looking at the proposed clinical change with a macro lens, there are many
interrelationships that may be affected. The macro lens is looking at the bigger picture and the
entities that may be affected by the change in this EBP. Clinical changes will have an impact on
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the healthcare system and society. Increasing education with a decision aid and a nurse
practitioner led shared decision coaching program will increase confidence between patient and
provider ensuring shared decision making is complete when discussing PSA testing. It will also
reduce mortality in prostate cancer because patients will have a better understanding of prostate
cancer and the risks and benefits of PSA testing.
The impact of the proposed clinical change is multifaceted and has significance across
the entire healthcare system. Each factor plays a vital role in the healthcare system and society. A
Nurse Practitioner led shared decision coaching program that utilizes a decision aid on improved
knowledge of prostate cancer, confidence in shared decision making for prostate cancer
screening and patient satisfaction yields influential outcomes that can be seen in both micro and
macro scales.
Contextual Factors
There are known contextual factors that can impact the implementation of the proposed
clinical change. The environment and socioeconomic status of each patient can affect the ability
to achieve the desired outcomes. A lack of transportation to coaching program would prevent
patients from receiving a nurse practitioner led shared decision coaching program. The
population of interest is individuals in protective service occupations, these must hold a high
school diploma or equivalent. This requirement will ensure that participants with have at least a
12th grade literacy level. This will be beneficial with the decision aid. Language may impact the
patient’s ability to understand the decision aid and prevent satisfactory communication between
patient and nurse practitioner.
Summary
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Factors that stem from the implementation of the proposed change are multilayered. It is
important to evaluate how the clinical change may affect the health system on both a micro and
macro level. It is established that this clinical change can affect both individuals and system
levels and are also interconnected. Certain contextual factors may positively or negatively affect
the implementation of the clinical change. The application of The Health Promotion Model
(1982) and Stetler Model (1976) both provide support to successfully increase engagement of a
Nurse Practitioner led shared decision coaching program that utilizes a decision aid on improved
knowledge of prostate cancer, confidence in shared decision making for prostate cancer
screening and patient satisfaction.
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Chapter Four: Proposed Clinical Change
The proposed clinical change, based on the evidence, is to implement a Nurse
Practitioner led shared decision coaching program that utilizes a decision aid which will improve
knowledge of prostate cancer, confidence in shared decision making for prostate cancer
screening and patient satisfaction. These changes are being implemented to improve knowledge
and shared decision making between a patient and nurse practitioner to help improve knowledge
regarding PSA testing which will lead to individuals having an informed decision and ensure that
there is participation between the patient and nurse practitioner in preforming shared decision
making. This chapter will discuss the details of the proposed change with an in-depth
description of the proposed clinical change, implementation, its stakeholders, data collection and
budgeting.
Description of Proposed Clinical Change
The proposed clinical change will first entail recruitment of the participants. Recruitment
will consist of the nurse practitioner contacting facilities that employ protective service
occupations such as police stations, firehalls and the district attorney’s office. The nurse
practitioner will discuss with the leadership in these offices the information about the study and
asking if it would be alright for flyers to be hung up on a bulletin board at each of the sites. The
flyer will provide specific information regarding the program and a QR code that individuals will
scan that will bring them to a short YouTube video (see appendix F). The YouTube video will be
2-3 minutes in length. The video will provide information on the study such as what the study is,
who is the targeted population and why it is important to participate in the study (see appendix
G).
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At the completion of the YouTube video, the individual will be led to a Google form for
them to provide their contact information if they are interested in participating in the study. The
Google form will be created with an email specific to this study. The nurses at the primary care
office will logged into the email associated with the Google form and will be notified when a
Google form is completed. After a nurse receives the notification that a form was completed,
they will contact the individual who completed the Google form and conduct a 4-question
screening to see if they meet the criteria for the study. If they meet the criteria the nurse will then
discuss the purpose and design of the study and review the informed consent with the patient.
Once this is completed the nurse will schedule them for the shared decision coaching session.
The patient will then be sent a text message by the nurse who reviewed the study and informed
consent with the patient. The texted link has the informed consent that was reviewed over the
phone and the pre-questionnaire. The patient will be asked to complete the consent and
questionnaire (see appendix D) prior to the decision coaching session and to bring them with the
patient to this decision coaching session for review and processing by the secretary in the office.
Next is the implementation of a Nurse Practitioner led shared decision coaching with the
use of a decision aid. The secretary will check the patient in and ensure that the informed consent
was completed. The secretary will give the patient the decision aid after the check-in process is
completed. The decision aid, implemented by Massachusetts Department of Public Health (see
Appendix B) is an in-office decision aid, it has a questionnaire that would be completed right
before the decision coaching with the nurse practitioner. The questionnaire consists of 6
questions that would establish if the patient had any risk factors for prostate cancer. It also
provides frequently asked questions about PSA testing.
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While waiting for the decision coaching session to begin the patient can complete the
questionnaire that is attached to the decision aid and read the frequently asked questions on the
decision aid. This will get the patient thinking about prostate cancer and PSA testing prior to the
session. The patient will be called to start the nurse practitioner led decision coaching session.
The nurse practitioner will review the answers of the decision aid questionnaire and assess the
patient’s risk of being diagnosed with prostate cancer. The conversation will consist of prostate
cancer education, secondary prevention measures specifically PSA testing, any concerns he may
have about PSA testing, along with the patient’s personal risk factors such as family history,
ethnicity and occupational or volunteer hazards. A motivational interview will occur between the
patient and nurse practitioner allowing the patient to ask any question he has about any of the
information that was discussed.
After the completion of the decision coaching session the nurse practitioner will give the
patient the post-questionnaire (see appendix D) to evaluate their knowledge of what was
discussed during the decision coaching. Once the patient has completed the post-questionnaire
the nurse practitioner will review the questions that he has gotten wrong and answer any
outstanding questions. This is to ensure that the patient will make an informed decision
regarding PSA testing. If the patient decides to participate in PSA testing the nurse practitioner
will put in the order for the nurses to draw the lab work. Prior to the nurse practitioner leaving
the room after a decision was made about PSA testing, they will give the patient the COMRADE
tool (see appendix C).
While the patient is waiting for the nurse to draw blood, he will have time to complete
COMRADE tool (see appendix C). The COMRADE tool consists of two questionnaires that
evaluate satisfaction with communication and confidence in decision making. If the patient
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decides against PSA testing, he will be able to complete the COMRADE tool prior to check out.
After, the nurse completes the lab work the patient will be directed to the front desk where the
secretary will then check them out and the patient will give the secretary his completed
COMRADE tool as well as the post-questionnaire. The secretary will place the tool in their
chart.
Once the PSA test has resulted in the patient’s chart, the nurse practitioner will contact
the patient and advise them on where to go based on the results. Individuals that do have an
elevated PSA greater than 4ng/ml will be referred to a urologist that will be associated with this
research. Individuals with a PSA greater than 2.5ng/ml should have their PSA tested on a yearly
basis; they will be asked if they would like to schedule that appointment at this time. Those with
a PSA less than 2.5ng/ml will need to be retested in two years unless symptoms of prostate
cancer occur. If this happens the patients are advised to contact the office for testing.
Data will be tracked with the data tracking sheet (see appendix J). Information that will
be tracked includes if the patient decided to have PSA testing done, if they were referred to
urology depending on their PSA level and if they followed-up with the urologist. The nurse
practitioner will oversee completing the tracking sheet.
Stakeholders
To successfully implement any clinical change, it is important to identify all probable
stakeholders who may be impacted by the clinical change. There are many stakeholders that has
been identified both internal and external to the primary care office setting. The primary
stakeholders involved in this clinical change are the nurse practitioner and the patient. The nurse
practitioner’s will be leading the decision coaching and participating in the shared decision
making. The patient will actively be participating with the decision aid and the decision coaching
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sessions. They will complete the decision coaching by making an informed decision on if they
would like to proceed with PSA testing. Nurses will be playing the role of screening patients
prior to making their appointment to establish if they qualify for the study. Other stakeholders
that will be impacted by the clinical change include secretarial staff, family members,
videography, IT, analyst, urologist, and insurance companies and possibly the employers
depending on if the patient is in a paid protective service occupation or volunteer.
Roles
When implementing a change in clinical practice, it is important to establish and
designate roles that each member will fulfill to complete the desired clinical goal. The primary
role of the nurse practitioner will be to lead the decision coaching session and provide
knowledge to the patient on anatomy and function of the prostate, risk factors of developing
prostate cancer, prostate cancer screening, prostate cancer symptoms and evaluate their specific
risk of developing prostate cancer. The nurse practitioner will also need to answer all questions
that the patient may have regarding prostate cancer and PSA testing. It is important that the
conversation leads to informed decision making and shared decision-making regarding PSA
testing, this conversation will be a motivational interview. The nurse practitioner will also review
the answers of the post-questionnaire with the patient after they complete it. Following the
results of PSA testing the nurse practitioner will also oversee contacting the patient with their
results and advising them on the correct course from there. The nurse practitioner will also need
to complete the data tracking sheet (see appendix J).
The role of the nursing staff will be to continuously check to see if there are notifications
from the Google forms of individuals interested in participating in the study. They will then
contact the patient after they give their contact information after the YouTube video. During the
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initial conversation between the patient and the nurse, the nurse will screen the patient to make
sure that they meet the study criteria and document the answers in the patient’s chart. The nurse
will then discuss the purpose and design of the study, will read, and review the informed consent.
Once this is completed the nurse will set up an appointment for the decision coaching session
and then send the patient via text message the informed consent and pre-questionnaire (see
Appendix D). The nursing staff will also have the role of drawing the PSA test if the patient
decides to have secondary prevention measures done.
Secretarial staff will have multiple different roles. They will first oversee checking the
patient in and ensuring that the informed consent was completed. After confirmation that the
informed consent is completed, the secretary will give the patient the decision aid (see Appendix
B) to be read and completed prior to the NP visit. The patient will hold onto the decision aid until
they are seen for decision coaching. At the end of the visit the secretarial staff will collect the
COMRADE scale (Appendix C) and the post-questionnaire (see Appendix D).
The role of the videographer will create a 2–3-minute YouTube video that describes the
purpose of the study and who qualifies to participate in the study. The IT department has the role
to create a QR code that will be on the flyer that is handed out at different protective service
employee places of work. The QR code will direct whoever is scanning it to the YouTube Video.
They will also set up the google form with an email that will be associated for with the study.
An analyst is needed to analyze the results of the pre- and post-questionnaire,
COMRADE tool and the number of patients that did vs. those that did not decide on following
through with PSA testing. This information can be found on the data tracking sheet (see
appendix J).
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The role of the urologist will be to be on standby for patients that do have an elevated
PSA and need to be referred to urology. The nurse practitioner will refer patients to the urologist
who have an elevated PSA testing. The nurse practitioner will keep track of this data on the
tracking sheet (see appendix J). The nurse practitioner will also be tracking if the patient attended
the appointment with the urologist.
Insurance companies will also be affected both positively and negatively. If an individual
is diagnosed with prostate cancer in a timely fashion treatment option may not be as serious as a
prostatectomy or radical prostatectomy. Instead, radiation can be a treatment option which would
be less invasive and more inexpensive than the surgical options. This will affect the insurance
companies in a positive way. The insurance companies will be billed for nurse practitioner led
decision coaching. It will be billed as a nurse practitioner visit. This will negatively affect the
insurance companies since they will need to pay for the visits.
Step by Step Description
Stetler’s Phases of Evidence-Based Practice
Phase One: Preparation.
The need of this evidence-based proposal was acknowledged by conducting preliminary
research on the topic. It was identified that protective service occupations are at a higher risk of
being diagnosed with prostate cancer. It was also noted that when USPSTF identified that
informed decision making, and shared decision making should occur when discussing and
deciding on going through with PSA testing, providers were not bringing up the topic of PSA
testing with their patients. Research has shown that the use of decision aids, health coaching and
shared decision making positively influence informed decision making regarding secondary
prevention measures such as PSA testing. To shape the purpose of the project, a PICOT question
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was formed: “Among protective service occupations, what is the impact of a Nurse Practitioner
led shared decision coaching program that utilizes a decision aid on improved knowledge of
prostate cancer, confidence in shared decision making for prostate cancer screening and patient
satisfaction over 12 weeks?”. Measurable outcomes that were identified were improved
knowledge of prostate cancer, confidence in shared decision making and patient satisfaction.
Phase Two: Validation.
A thorough review of the relevant and available literature published within the last two
years except for two articles that we published in 2015 and 2012. The literature review was
conducted to gather credible evidence for this proposal. Multiple search strategies and databases
were used to compose the literature that was reviewed for this proposal. A matrix of literature
was completed to analyze the strengths, weaknesses, and similarities of each study and to
appraise the evidence (see Appendix A).
Phase Three: Comparative Evaluation/Decision Making.
Once the findings had been summarized and organized in the matrix (see Appendix A), a
full synthesis of the evidence was conducted. From there three themes emerged: 1) Shared
Decision Making; 2) Community Health Workers and Motivational Interviewing; and 3) The
Use of a Decision Aid. The use of a decision coach and decision aid was proven to improve
knowledge along with improving communication and satisfaction. Based on the findings a
decision was made to put this evidence-based knowledge into effect and move forward with the
proposal.
Phase Four: Translation/Application.
Once the evidence-based intervention was determined, a plan for implementation in a
primary care setting was constructed. The application of proposed change was described earlier
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in this chapter. The proposed change included identifying the relevant stakeholders, their roles,
and responsibilities, and how the change will be interpreted into the workflow or clinical change.
Adequate education for all stake holders will be necessary and a formal education session will be
provided.
Phase Five: Evaluation.
To evaluate the success of the clinical change, various anticipated outcomes will be
clarified. We will evaluate the knowledge with a pre- and post- questionnaire (see Appendix D)
to establish if each patient benefitted from the decision coaching. This pre- and postquestionnaire was used in Owens et al, (2018) article. This EBP uses the COMRADE tool to
evaluate satisfaction and confidence with decision making (Appendix C) (Edwards et al., 2003).
A cost-benefit analysis will be conducted to evaluate the feasibility of the proposed clinical
change. The data collection and analysis procedures and the cost benefit analysis process will be
outlined in further detail in the chapter.
Workflow and Responsibilities
For this proposed clinical change to occur, a few alterations in the workflow be
implemented. To recruit patients for this clinical change, the recruiting process will be completed
by nurse practitioners. The nurse practitioners will contact firehalls, local police stations and the
district attorney’s office. The nurse practitioner will speak to either the individual in charge and
will explain the study that will be conducted and seek permission to hang up flyers on bulletin
boards. Once permission is received the nurse practitioner will go to these sites to hang up the
flyers. The nurse practitioner and IT department will team up to create a flyer (see Appendix F)
that contains information about the study and a QR code that will scan and bring up a YouTube
video that will provide information about the study.
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The responsibilities for IT include developing a QR code for the informative flyer (see
Appendix F) and creating a function that after the YouTube is completed the webpage is
redirected to a Google form to fill out contact information that will be sent to the primary care
office for those who are interested in participating in the study. The IT department will also
oversee setting up the google form with the email associated with the study. The videographer
will work with the nurse practitioner to create the short 2–3-minute YouTube video about the
study. The responsibility of the videographer is to create the YouTube video that is informative
to the viewer. The information contained in the YouTube video will be who is at risk for prostate
cancer, what this study is, and the criteria needed to be met to participate in the study. At the
completion of the video the IT tech will set up the video to automatically open a Google form for
the individual watching the video. The Google form will allow them to input their name and
contact number if they would like to participate in the study. The Google form will be created
under an email that is specific for this study. Once the patient inputs their contact information
and submits the information, a notification will be sent to the specific email that is monitored by
the nursing staff at the primary care office.
The nursing staff has a plethora on responsibilities in this clinical change that occur in
different times during the change. The screening questions will include age, gender, occupation,
and previous diagnosis of prostate cancer. The criteria that would allow the individual to
participate in the study would be age greater than 40 years old, male, no previous diagnosis of
prostate cancer and protective service occupation. The nurse will document this information in
the patient’s chart. Once the nurse verifies that the individual calling meets the criteria the nurse
will explain the purpose and design of the study and to read and explain the informed consent to
the patient. If the patient wishes to continue the nurse will be responsible for scheduling them for
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the nurse practitioner led decision coaching session. Once the appointment is scheduled the nurse
will send the informed consent and pre-questionnaire via text to the patient to complete prior to
the decision coaching session. Later in the clinical change the nurse will be responsible for
checking the patient’s chart to see if the nurse practitioner ordered PSA testing, if the nurse
practitioner did order PSA testing the nurse will be responsible for going to the patient’s room
and drawing the blood for the test.
Once the patient arrives at the office for the nurse practitioner led decision coaching
session, the patient will be checked in with the secretarial staff. The staff will be expected to
check in the patient in a timely manner and ensure that the patient has completed the informed
consent. Once it is established that the patient has completed the informed consent and the
patient is checked in the secretary will give the patient the decision aid (see Appendix B). The
decision aid offers education or frequently asked questions regarding prostate cancer. The
decision aid also has six questions that the patient will fill out. The questions specifically address
the patient’s individual risk for developing prostate cancer. The patient will hold onto the
decision aid until the coaching session begins with the nurse practitioner. The responsibilities of
the secretarial staff include checking the patient in, printing all documentation such as decision
aids and questionnaires, making sure all documents have associated number to the patient to
maintain confidentiality, keeping track of questionnaires ensuring that are completed. The
competed questionnaires are needed to analyze the results of the study. The secretarial staff will
also check the patient out and ensure that the patient’s chart has the correct contact information.
Once the patient is checked in and the decision aid is completed the patient will be called
into a room to begin the NP led decision coaching session. Since the nurse practitioner is one of
the primary stakeholders in this clinical change, they have many responsibilities. The nurse
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practitioner’s responsibilities include ensuring that the NP is properly educated on what they
need to educate the patient on such as prostate cancer knowledge, risk factors, symptoms, or
secondary prevention measures. This is important because the nurse practitioner will be
educating the patients on this information. Other responsibilities include actively encouraging the
patient to participate in the conversation and encouraging the patient to participate in the shared
decision-making regarding PSA testing. This will happen in a back-and-forth conversation and
will be considered the motivational interviewing. The nurse practitioner will also oversee the
ordering of PSA lab test if that is what both the patient and they decided on. The nurse
practitioner is also responsible for reviewing answers to the post-question to ensure that the
patient understands all the information that was discussed in the session. Later in the clinical
change, the nurse practitioner will be responsible for contacting the patient and discussing results
of the PSA test. Depending on the PSA test results, the nurse practitioner will then suggest the
next steps for the patient whether that be referring them to a urologist or scheduling another
appointment to see the patient.
The nurse practitioner will take on the role as a decision coach which will be different
from their role as a nurse practitioner. In this clinical change the nurse practitioner will lead one
on one decision coaching appointments with each patient. Topics of conversation that the nurse
practitioner will discuss during the decision coaching will include the anatomy and function of
the prostate, symptoms that correlate with prostate cancer, screening measures and risk factors.
The nurse practitioner will also discuss each patient’s specific risk factors of developing prostate
cancer. These risks were established when the patient answered the 6 questions on the decision
aid (see Appendix B) that was given by the secretarial staff. The patient will ask all questions
that they may have regrading prostate cancer knowledge, risk factors, symptoms, or secondary
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prevention measures. With the patient being able to ask the nurse practitioner questions
regarding PSA testing and risk factors for developing prostate cancer this leads to informed
decision making. At the end of the decision coaching session the nurse practitioner will give the
post-questionnaire for the patient to complete. Once completed the nurse practitioner will go into
the patient’s room to review the answers of the post-questionnaire (see appendix D). This is
important as the patient should understand the correct answers and rationale as to why they are
the correct answers. Having the correct information should allow for the patient to make an
informed decision regarding PSA testing.
Once the questionnaire has been reviewed and the patient has a better understanding of
everything that was discussed in the nurse practitioner led decision coaching session the nurse
practitioner and patient will use shared decision making to decide if the patient should through
with PSA testing. The patient will need to give the nurse practitioner a yes or no regarding
testing for PSA at this visit. The nurse practitioner will record their answer in the data tracking
sheet (see appendix J). If the patient does decide to follow through with getting PSA testing done
the nurse practitioner will order the PSA test. Before leaving the room, the nurse practitioner will
give the COMRADE tool (see Appendix C), the patient will have time to complete the tool while
they wait for the nursing staff to come in and draw blood or before they leave if they have
decided not to complete the PSA test.
Once the order for the PSA test has been placed, the nursing staff will get a notification
for a blood draw. The nurse will gather materials and head to the patient’s room to draw the lab
work. Once the nurse is done obtaining the blood work, and the COMRADE tool is complete the
patient will be directed to bring paperwork to the front desk and check out. The patient will turn
the completed questionnaire and COMRADE tool to the secretary. The secretary will place the
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questionnaire and COMRADE tool in the designated folder. Once the patient is checked out, the
nurse practitioner led decision coaching session is completed.
After the completion of the decision coaching session, the data tracking and analysis will
begin. The responsibility of the analyst is to transcribe and evaluate all the data that was
collected. The data includes screening information that included demographics, the pre- and
post-questionnaire, the COMRADE tool, and those who followed through with PSA testing.
While the data is being analyzed, the nurse practitioner will be checking for results of the
PSA for the patients. One the PSA test has resulted the nurse practitioner will contact the patient
to review their results. Based on the results, the nurse practitioner will decide on the plan for
follow-up. The nurse practitioner will follow these guidelines for deciding follow-up. Those with
a PSA less than 2.5ng/ml will need to be retested in two years unless symptoms of prostate
cancer occur. The nurse practitioner will encourage the patient to schedule an appointment in one
year for a yearly physical. If the patient is willing the nurse practitioner will schedule that
appointment while on the phone with the patient. Those with a PSA greater than 2.5ng/ml should
have their PSA tested on a yearly basis. They will also be asked if they would like to schedule
that appointment at this time. For patients with an elevated PSA greater than 4ng/ml, they will
be referred to a urologist.
There will be an active urologist that will accept transferring of patients with an elevated
PSA greater than 4ng/ml. The responsibility of the urologist will be to take over care of the
patient with the elevated PSA and continue diagnostic tests to establish the diagnosis of prostate
cancer. The nurse practitioner will make a note in the patients charts who are transferred to
urology and follow up with them in 1 month to evaluate if they attended the appointment with
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the urologist. Patients that were transferred to urology and the one month follow up will be
tracked on the data tracking sheet (see appendix J) by the nurse practitioner.
Education Plan
An organized educational plan is required for successful implementation of the proposed
clinical change. Education will first occur with secretarial staff, nursing staff and the nurse
practitioners. After that occurs, education must take place with the patients and other
stakeholders.
Education for the secretarial staff, nursing staff, and nurse practitioners is essential for
implementation of the proposed clinical change. The secretarial staff must be educated on the
data collection process and proper location to place completed post-questionnaires and
completed COMRADE tools. The nursing staff will have extensive education on contacting the
patient and understanding the screening questions that must be answered to evaluate if a patient
can participate in the study. The nursing staff will also be educated that they need to specify what
the informed consent entails and review it with the patient. They will also be educated on how to
send the informed consent and pre-questionnaire to the patient once it has been established that
they meet the criteria to participate in the study. Appendix H has education materials for the staff
and specifically the nurses who will be involved in the EBP (see appendix H). Scheduling
appointments and obtaining laboratory blood draws is already part of the nursing staff job
description. Extra education is not required for those two areas.
Education for the nurse practitioner is essential since they are the primary stakeholder in
this clinical change. The nurse practitioner must be agreeable to the decision coaching sessions
and be educated on the use of a decision aid to improve prostate cancer knowledge, and shared
decision making between them and the patient. The nurse practitioners must also be educated on
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prostate cancer and the decision coaching program. Appendix I has the educational materials and
plan for the nurse practitioner.
The second phase of the education plan will include providing patients with educational
materials. The decision aid (see Appendix B) that was given at the beginning of the appointment
contains information about PSA testing and frequently asked questions regarding PSA testing.
Desired Outcomes
The aim of the proposed clinical change is to increase the knowledge of prostate cancer
for protective service occupations and improved satisfaction with shared decision making and
improved confidence in decision making regarding PSA testing. The success of these outcomes
will be measured via the collection of data from a pre- and post- intervention questionnaire that
will assess the level of knowledge. The COMRADE questionnaire will measure both improved
satisfaction and improved confidence. The desired outcomes of this evidence-based proposal are
increased shared decision making with prostate cancer screening in protective service
occupations. This will be tracked using the COMRADE tool. The COMRADE tool will track the
satisfaction in the conversation and confidence in decision making. All patients will complete
this after the nurse practitioner led decision coaching. Multiple studies indicated that a use of a
decision aid and community health workers can produce these outcomes (Alizadeh-Sabeg et al.,
2021; Brandford et al., 2018; Portillo, Vasquez & Brown, 2020).
Data Collection
A plan for data collection is necessary to ensure that outcomes of the clinical change can
be properly evaluated.
Knowledge. Collecting data before the intervention then after can illuminate the overall
success in improving knowledge about prostate cancer, satisfaction, and confidence. Data
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collection methods include a pre- and post-questionnaire (see Appendix D) that will be given to
individuals before their decision coaching session. Willingness to participate in the study will be
expressed upon the patient attending to scheduled appointment. The pre-questionnaire will be
sent via text message along with the informed consent. This will be sent by the nurse after the
nurse discuss the purpose and design of the study and reviews what the informed consent entails
with the patient. Upon arrival the patient will check in with the secretary and the secretary will
confirm an informed consent was completed. Once this occurs the secretary will give the patient
the decision aid to read over and complete while waiting for the nurse practitioner led decision
coaching session to begin. The patient will be escorted to a room and will complete the decision
coaching session. At completion of the decision coaching session the patient will be given the
post-questionnaire to complete. Once completed the nurse practitioner will review the answers
with the patient to ensure all questions were answered correctly and that the patient understands
all the information. The patient will then be asked to decide if they would like to follow through
with PSA testing.
Satisfaction and confidence. After a decision is made the nurse practitioner order the PSA
test and will then give the patient the COMRADE tool to fill out. After the nurses have
completed the PSA testing, the patient will then return the post-questionnaire and COMRADE
tool to the secretarial staff at check-out.
Shared Decision making. The tracking tool that will be used to keep track if patients have
decided on PSA testing and if they needed to be referred to urology and the tracking of patients
following through with urology will all be tracked on the data tracking tool (see appendix J). The
nurse practitioner will keep track of this tool and mark yes or no to what patients have decided
on PSA testing and the follow-up process.
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All data that is collected will be kept in secure files without identifiable information. All
paperwork will have a unique number that is associated with that patient. All paperwork will
have the number on it to avoid personal information such as name or date of birth to remain on
the paperwork.
Data Analysis and Evaluation Plan
Knowledge. Once all the data has been collected, a data analysis will be conducted to
determine if the intervention was successful or not. Scores on the pre-questionnaire will be
recorded on a data tracking tool and scores on the post-questionnaires will also be recorded on a
data tracking tool. Using descriptive statistics, a change in scores will be calculated to determine
the percentage of improved knowledge resulting from the decision coaching session.
Satisfaction and confidence. The COMRADE questionnaire will be evaluated for the
percentage of improved satisfaction and confidence in the patient decision making. The
COMRADE tool uses the Likert scale to measure a participant’s satisfaction and confidence in
decision making.
Shared decision making. Data will also be analyzed to see the percentage of individuals
who followed through with getting PSA testing done after attending the nurse practitioner led
decision coaching verse those who did not follow through with PSA testing. This will be tracked
using the data tracking sheet (see appendix J).
A descriptive change will be used to determine if there was an association between the
intervention and improved knowledge of prostate cancer, improved satisfaction and confidence
in shared decision making for prostate cancer screening. It is anticipated that those who are
educated with information that they learned in the nurse practitioner decision coaching will score
better on the post-questionnaire and have higher rates of satisfaction and confidence.
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Communication Plan
Communication about the proposed clinical change will ensure proper implementation of
the process. It is a necessary component to the clinical change. It will be necessary to discuss
how the clinical change will affect the workflow for all the stakeholders and how it will be
communicated to everyone. The plan will first start with a brief in-person meeting with
secretarial staff, nursing staff and nurse practitioners to notify them of changes that will be put in
place for them. There will be a discussion about the paperwork such as the decision aid that will
be handed out at check in along with paperwork that will be collected at the completion of the
appointment. The roles and responsibilities will be communicated for all involved with the
clinical change. It is important to allow time during the meeting to give staff members time to
ask questions or give concerns they may have. Contact information will be given to staff if they
have any more questions or concerns, they can reach out. Additional meetings will be provided
on an as needed basis to ensure readiness for implementation.
Once the results of the study have been determined, communication of the results to the
stakeholders is important. It is important to notify the stakeholders with the results of the study, it
is important because they need to know what they will need to do to sustain the change.
Stakeholders such as the nurse practitioners will need to adapt to shared decision making and
informed decision making to sustain the change. Patients will need to be comfortable with using
motivational interviewing during the coaching sessions this will help sustain the informed
decision making and shared decision making. Once the data and results are finalized the
information will be presented on large graphs and flyers. Graphs and flyers will be presented in
the front of the office for other patients to see. The results will also be shared with the second
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office during the monthly meeting with providers. This will help with expansion of the study to
this site. The results will also be present in the front of the second office as well.
Timeline
The timeline for implementation of the proposed clinical change will be in accordance
with the five specific phases of the Stetler Model (1976). Below is a table that summarizes the
timeline for this evidence-based project.
Step of Project

Timeframe

Phase One: Preparation

2 weeks

Phase Two: Validation

3 weeks

Phase Three: Comparative Evaluation/Decision Making

5 weeks

Phase Four:


Translation (communication of the change,

5 weeks

training, acquiring materials)


Application (implementation)

12 weeks

Phase Five: Evaluation

8 weeks

Total Time

35 weeks

During phase one a clinical problem was identified, and a clinical question was
formulated. After two weeks of extensive thorough search of research a formal PICOT question
was established. Measurable outcomes of the clinical question were considered.
During phase two a collection of evidence and an extensive review of literature was
completed. Once this was completed the evidence was placed and organized into a matrix. Three
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weeks was given for completion of the review of literature and matrix. Once the matrix was
completed, phase three was able to begin.
During phase three the evidence that was found in the previous phase was synthesized
and three themes were transpired. Phase three took five weeks. During the five weeks the best
evidence was identified. A decision was then made to move forward with the implementation.
Phase four is the most extensive phase with two different components of the phase. The
first component of phase four is translation, five weeks was given for this phase. The second
component of phase four is application, twelve weeks was allotted for this phase. This will give a
total of seventeen weeks for phase four. In the five weeks of the transition section introduction of
the clinical change and preparation. Communication of the clinical change to the stakeholders
that is outlined in the “Communication Plan” section will also occur during those five weeks.
Education about the clinical change and its translation into the workflow will occur via in-person
meetings with staff, along with training sessions. During this five weeks, essential materials such
as printing of the decision aids and questionnaires that are essential for the implantation phase
will be obtained. The following section in phase four, application is when the clinical change
will be applied. Over the twelve weeks the nurse practitioner will lead decision coaching
sessions to first responders. Patients will be given the decision aid, pre- and post- questionnaires
along with the COMRADE forms that need to be completed. Sufficient time is allotted to ensure
for data collection. At the end of the twelve weeks, no longer data will be completed.
The final phase, phase five entails an examination of the data that was collected. After an
examination of data, an evaluation of the success of the clinical change is completed. The costeffectiveness of the clinical change will also occur during this phase. Once completed the results
of the clinical change will be communicated with the stakeholders. Communication with the
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stakeholders is important during this phase to ensure that the changes that occurred will be
sustained. Anticipating that the results will be beneficial, talk on expanding this study will also
occur in this phase. Phase five will take a total of eight weeks to be completed.
Budget
An assessment of the budget is an important step when considering the implementation of
the clinical change. The cost will be a major determinant of whether an intervention is feasible or
not. It is necessary to examine the potential cost to both the primary care office and the patients
that will be participating. A complete budget table for implementation, with all associated costs
can be seen in Appendix E.
Costs that are included in the budget include meeting and presentation preparation, staff
attendance at meetings and training sessions, materials, videographer, IT, and compensation. Ten
hours will be allotted to the change leader (nurse practitioner). Included in these 10 hours are
time to prepare for the staff education meetings, time to prepare for education of recruitment site
leaders, development of a marketing plan for contacting employers to discuss the study and ask
for permission to hang up flyers for the study, and time it takes to drive to each location for
distribution of the flyers. Compensation for travel costs will be at current NYS mileage
reimbursement.
Staff will be expected to attend a training session that will be accounted for in the
organizational costs. Attendees will include the lead physician, two nurse practitioners, one
physician assistant, one registered nurse, two licensed practical nurses, one office manager and
two secretaries. Everyone will be trained on the decision aid, pre- and post-questionnaire, and the
COMRADE tool and how collection procedures will transpire. They will also be informed of
screening measures that need to be completed during the initial phone call with the patient and
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locating the informed consent to see if it has been completed or not. They will also be informed
on the anticipated outcomes of the clinical change. Salary and estimated wages have been
estimated using ziprecruiter.com for the geographical region. Material costs will cover patient
resources and data collection tools (see Appendix B, C, D) along with the recruitment flyer (see
Appendix F) and a brief educational sheet for staff.
Lastly, it is important to understand the costs which may be incurred by the patient.
These costs are highly variable as each patient’s insurance situation varies. It is presumed that
most patients will have insurance seeing that they are occupied in protective service occupations,
but everyone’s financial situation is different. Direct costs that may occur include visit copays
and the cost of a lab draw. It is presumed that this will all be covered under the patient’s
insurance.
Return on Investment
Return on investment is an important factor to consider with the implantation of any
clinical change (see appendix E). In this specific study there is a great gain on the return of
investment. The nurse practitioner led decision coaching session will be billable hours which will
improve the return on investment. The program itself will bring more patients into the primary
care setting thus leading to more yearly physicals, sick visits etc. All these appointments will be
billable hours and return on investment. Insurance companies will also see a return on
investment with having less invasive procedures such as radiation verses a radical prostatectomy.
The COMRADE tool that is part of the clinical change that measures satisfaction. The
goal is to have improved satisfaction at the conclusion of the study. Improved satisfaction will
benefit the office by word of mouth. If the participates are satisfied with the experience they had
during the study, they will refer their friends to become patients at the facility. This will increase
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profit related to an increase in patients. In this case, the primary care office will not lose money
due to the implementation of the clinical change.
Summary
This chapter discussed putting the clinical change into motion. Stakeholders and their
roles were discussed along with the education plan that needs to be in place to educate everyone
on the clinical change. There were other factors that determine if an implementation of a new
clinical change is feasible. The budget was discussed along with the return on investment that
shows that this clinical change is feasible and that the clinical change will not negatively affect
the primary care office.
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Chapter Five: Conclusions
Evidence-based practice guides clinical changes that better communication for patientcare delivery. When implementing an evidence-based intervention, it is important to observe the
potential impact that the change could have on the healthcare system. The anticipated outcomes
should be assessed to consider the risks and benefits of implementing the change in the current
primary care practice. The aim of this evidence-based project is to develop a program to increase
knowledge in protective service occupation individuals about prostate cancer and PSA testing,
along with improving satisfaction with shared decision making and confidence in informed
decision making in a primary care setting.
Potential Impact
The implication of this evidence-based proposal in a primary care setting has the
potential to impact many aspects of the health care system. Those affected by the change will
include patients and nurse practitioners. Patients will have an improved knowledge of prostate
cancer and secondary prevention measures. This proposal will lead to improved shared decision
making between the nurse practitioner and the patient, this will change how providers and
patients decide on PSA screening. With the early and appropriate prostate cancer screening we
will have earlier identification of prostate cancer leading to earlier and less invasive treatment
options. With less invasive treatment options, the patient should maintain a better quality of life
and costs of care will be contained for both the insurance companies and the patients.
The impact that this evidence-based proposal will have on the nurse practitioner will
include improved communication skills with patients. The improved communication skills will
cross over to other patients that the nurse practitioner is treating. This will improve overall rating
at the primary care office and lead to more individuals wanting to become patients at that office.
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Anticipated Outcomes
With the implementation of this evidence-based proposal, the main anticipated outcome
is improved knowledge of prostate cancer, along with improved satisfaction and confidence in
shared decision-making regarding PSA testing. The evidence provided indicates that the decision
coaching and the use of a decision aid can improve knowledge, satisfaction, and confidence.
Based on literature, it is predicted that the use of a decision aid and community health worker
working together improved knowledge (15.0 v. 10.9; P = 0.01), participation (COMRADE 79.5
v. 69.7; P = 0.03), and satisfaction (odds ratio 1.49; 95% confidence interval, 1.11–2.01; P =
0.008) compared to usual care (Stacey et al., 2012). This EBP proposal utilizes the NP as the
community health worker and is anticipated to yield similar results.
Secondary outcomes are also likely to result from this intervention. It is anticipated that
the patients will be more aware about prostate cancer, secondary prevention measures and
symptoms related to prostate cancer. Increased awareness will allow for future early
identification of a potential need for PSA screening. Finally, a secondary outcome may be that
the patients become more aware of their goals, values, and preferences about secondary
prevention measures.
Implications for Practice
There are many practice implications highlighted in this evidence-based proposal. The
first implication is for nurse practitioners to take on a role of providing shared decision making
and informed decision making regarding prostate cancer and PSA testing. Prostate cancer is the
most diagnosed cancer in the United States, and it is recommended that PSA testing is based on
shared decision making and informed decision making between the provider and the patient. The
nurse practitioner is the most ideal individual to provide the intervention identified in this
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proposal because nurse practitioners are trusted by the community. Other implications include
the patient participating in shared decision making and informed decision making. This is
projected in the decision coaching and reviewing the answers of the post-questionnaire before
deciding on PSA testing or not. The main goal of this intervention is to help those identified
establish their risk factors of prostate cancer and identify their desire to follow through with PSA
testing.
Sustainability
Once the data analysis has been completed and there is a demonstrated improved
knowledge of prostate cancer, increased satisfaction with shared decision making, and improved
confidence regarding PSA testing it will be important to expand this program. This program will
first expand to other primary care offices. Nurse practitioners will travel to other primary care
offices that have in house laboratory testing. Education will be provided to all employees and the
nurse practitioner will stay at the new sites to oversee the beginning of the clinical change and be
available to answer questions when needed. Once the program has been started flyers will be
given out to other protective service occupation employers to gather more individuals to
participate at the new primary care offices. Other locations that employee protective service
occupations include factories such as General Mills and with the proximity to the Canada Border
it would be beneficial to reach out to Border Patrol to implement them into the study. Both
occupations would fall under the protective service occupations and could potentially be at an
increased risk of developing prostate cancer.
Future EBP Project/Research
With completion of this evidence-based proposal supporting the implementation of a
nurse practitioner led decision coaching with the use of a decision aid in the primary care setting,
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there may be other areas of inquiry that could benefit from this evidence-based proposal. One
area of future exploration would be to implement this proposal in other occupations that were
identified in chapter one as an increased risk of developing prostate cancer including
management and administration, farming, construction, and transportation (Sritharan et al.,
2019). It would be feasible to identify these individuals in other occupations and bring them into
the primary care office and establish the nurse practitioner led decision coaching sessions with
them.
Another area of future exploration would include completing this research then start a
qualitative research study with the individuals that participated in this current evidence-based
proposal. In the qualitative study, there would be in person interviews with the protective service
occupation participants. Topics of conversation would include how they felt about the program
and any recommendation they would have about the program. The qualitative research study
would improve the program and identify any changes that may be needed. Other ideas to expand
nurse practitioner decision coaching would include provide the decision coaching to other
diseases that would benefit from the coaching such as breast cancer. It was identified in
Alizadeh-Sabeg et al (2021) that motivational based coaching increased individuals breast cancer
screening behaviors.
Summary
The purpose of this evidence-based proposal was to examine the effectiveness of nurse
practitioner led decision coaching using a decision aid to improve knowledge of prostate cancer,
improved confidence in shared decision making for prostate cancer screening and patient
satisfaction. After a thorough review and synthesis of the available literature and evidence, it was
determined that decision coaching with the use of a decision aid were effective to improving
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knowledge, confidence, and satisfaction. The following clinical question was developed: Among
persons who are in protective service occupations, what is the impact of a Nurse Practitioner led
shared decision coaching program that utilizes a decision aid on improved knowledge of
prostate cancer, confidence in shared decision making for prostate cancer screening and patient
satisfaction over 12 weeks? To answer this question a clinical change was proposed which
involved the implementation of a nurse practitioner led decision coaching with the use of a
decision aid. An extensive plan was discussed for the implementation of the proposed clinical
change and a thorough evaluation of all components were completed. All components of the
clinical change were considered with guidance of the nursing theory Health Promotion Model
(Pender, 1982) in conjunction with the steps of the evidence-based proposal model Stetler Model
(1976). A plan was developed for the evaluation of the clinical change, including strategies for
data collection and analysis. With meaningful data, a decision can be made to move forward with
incorporating the nurse practitioner led decision coaching with the use of a decision aid into the
primary care setting with the hopes to improve knowledge of prostate cancer, confidence in
shared decision making for prostate cancer screening and patient satisfaction in protective
service occupations.
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Appendix A: Matrix of Evidence

Reference

Description/ Summary –

Analysis/Evaluation –

Kim, K., Choi, J. S., Choi, E., Nieman, C.
L., Joo, J. H., Lin, F. R., Gitlin, L. N., &
Han, H.-R. (2016). Effects of communitybased health worker interventions to
improve chronic disease management and
care among vulnerable populations: A
systematic review. American Journal of
Public Health, 106(4).
https://doi.org/10.2105/ajph.2015.302987

Main Points:
Strengths:
 Community-based health
 30 studies out of 67
workers (CBHWs)- public
involved CBHWs for
health workers who are trusted
cancer prevention.
members of the community
they serve.
Weaknesses:
 CBHWs tending to save on
 None of the cancers in
costs.
the studies were prostate
cancer.
 CBHW interventions are
effective in promoting a wide
Why included:
range of heathy behaviors
such as breast cancer
 most studies focused on
screening, self-management of
preventing cancer and
diabetes, hypertension, and
cardiovascular disease.
asthma.
 Touched base on cost
outcomes with CBHWs
Research Type:
 Explained qualifications
 Systemic review
and characteristics of
CBHWs
Purpose:
 Provide a critical review of the
evidence on CBHW
interventions. Specifically,
examining the types of
interventions in which
CBHWs are employed, the

Synthesis –
Light of the Whole
How relates:
 CBHWs play an
essential role in
bridging between
the health care
services and the
communities
they serve.
Similar:
 Describe benefits
of CBHW.
 CBHW used in
collaboration
with providers.
Differs:
 Provided range
of CBHW with
multiple disease
processes.
Level of Evidence:
 Level I
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qualifications and
characteristics of CBHWs and
the patient’s outcomes and
cost effectiveness of such
interventions in vulnerable
populations with noncommunicable chronic
conditions.
Main Findings:
 CBHWs delivered a wide
range of interventions
including education,
counseling, navigation
assistance, case management,
social services, and social
support.
 CBHW interventions were
performed in collaboration
with health care professionals.
 21 out of the 30 CBHW-led
intervention on cancer control
found improvements in cancer
screening behaviors.
 Positive changes in
mammogram uptake were
noted in 9 out of 16 articles.
Conclusions:
 CBHW interventions were
effective in promoting CVD
risk reduction, cancer
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Owens, O. L., Felder, T., Tavakoli, A. S.,
Revels, A. A., Friedman, D. B., HughesHalbert, C., & Hébert, J. R. (2018).
Evaluation of a computer-based decision
aid for promoting informed prostate cancer
screening decisions among African
American men: Idecide. American Journal
of Health Promotion, 33(2), 267–278.
https://doi.org/10.1177/0890117118786866

screening and cognitive
functioning.
 CBHWs play an essential role
in bridging between the health
care services and the
communities they serve.
 Can be an effective
intervention model that is also
cost effective for certain
health conditions
Main Points:
 PSA test can lead to over
treatment of indolent PrCA.
 American cancer society
(ACS), American urological
association, and the US
preventative services task
force to recommend informed
decision making (IDM) with
healthcare provider to
determine whether to receive
PSA screening for PrCA or
not.
 Informed decision making is
characterized by a patient
having a clear understanding
about the disease, possessing
knowledge of the risks,
benefits, and uncertainties of
screening and subsequent
treatment, and actively
engaging in a level of
decision-making desired.

Strengths:
 Study approved by
institutional review
board
 Large Sample size
Weaknesses:
 Participants resided in
one location.
Why included:
 Asked if they have had
discussion with doctor
about PrCA before.

Light of the Whole:
How relates:
 iDecide is an
effective
resource for
increasing PrCA
knowledge.
Similar:
 Discussed SDM
 Computer based
decision aid.
Differs:
 Does not
mention the use
of iDecide and
SDM.
Level of Evidence:
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Men receiving an IDM
intervention reported
significant increase in
knowledge about PrCA
compared to control group.

Type:
 Experimental study.
Purpose:
 To evaluate the effects of
iDecide on prostate cancer
knowledge, informed
decision-making self-efficacy,
technology use self-efficacy,
and intention to engage in
informed decision-making
among African American
men.
Main Findings:
 Research suggests men
involved in IDM have
numerous benefits such as
improved knowledge, reduce
delusional conflict, higher
IDM self-efficacy.
 Increase in knowledge of
prostate cancer
 Categories of highest change
were screening, anatomy,
symptoms



Level I

75





Rim, S. H., Hall, I. J., Massetti, G. M.,
Thomas, C. C., Li, J., & Richardson, L. C.
(2018). Primary care providers’ intended
use of decision aids for prostate-specific
antigen testing for prostate cancer
screening. Journal of Cancer
Education, 34(4), 666–670.
https://doi.org/10.1007/s13187-018-1353-5

Lowest change were risk
factors
Increase in participants
confidence to figure out the
best screening choice &
asking medical question
without feeling dumb.
Postintervention respondents
reported that they planned to
make an informed decision
with their health care provider
about whether to receive a
PrCA screening within the
next 6 months or mot.

Conclusions:
 iDecide led to significantly
higher overall knowledge
across all domains.
 iDecide a CBDA designed for
individuals of varying literacy
levels, greatly improved their
existing PrCA knowledge.
Main Points:
 Decision aids are tools
intended to help people weigh
the benefits and harms of
health decisions.
Type:
 Randomized Control Study
Purpose:

Strengths:
 70.5% response rate for
PCP and 41.3% for NPs.
 Medium time of NP
practicing medicine
were 14 years.
Weaknesses:
 Study did not
differentiate between the

Light of the Whole:
How relates:
 Gives
explanation of
reasons why
SDM may not be
occurring and if
providers are
willing to
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Examine current primary care
providers perspectives on use
of decision aids.

Main Findings:
 Only 11% of providers
currently use a DA when
discussing PSA with pts.
 35% of practitioners do not
use a DA and were NOT
interested in using one.
 54% currently do not use a
DA but are interested in
learning about incorporating
one into their practice.
 52% of providers responded
that they decided together with
their patients/family member
about PSA testing.
Conclusions:
 Provider receptivity towards
tools can assist in and
supplement these
conversations about PSA
testing.
 Biggest impact in increasing
PCP use may be targeting
family practitioners who were
most likely to not currently
use a DA but were interested
in using one.

use of a patient DA and
a physician DA.
Why included:
 Questions pertaining to
prostate cancer
screening were limited
to primary care
physicians and nurse
practitioners.
What learned:
 Many practitioners
routinely offer and
recommend PSA for all
asymptomatic pts.
Regardless of whether
patient asks.

participate in
SDM.
Similar:
 Focused on
primary care
settings.
Differs:
 Providers
opinion on SDM.
Level of Evidence:
 Level I
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Stamm, A. W., Banerji, J. S., Wolff, E. M.,
Slee, A., Akapame, S., Dahl, K., Massman,
J. D., Strong, M. C., Pittenger, K. R., &
Corman , J. M. (2017). A decision aid
versus shared decision making for prostate
cancer screening: results of a randomized,
controlled trial. The Canadian Journal of
Urology , 8339–8346.

Main Points:
Strengths:
 Shared decision making
 Approved by the
(SDM) is widely encouraged
Benaroya Research
by both American Urology
Institute at Virginia
Association and Choosing
Mason’s Institutional
Wisely for prostate cancer
Review Board.
screening.
 Done in the U.S.
 SDM is challenging due to
 Questions developed by
time restraints and competing
research team based on
patient priorities.
content in the VMMC
 Strategy to mitigate the
prostate cancer
difficulties in implementing
screening DA
SDM is to utilize a decision
 High return rate of
aid (DA).
questionnaires.
 U.S. Preventive Services Task
 Inclusion of patients
Force (USPSTF) guidelines,
from multiple providers.
which recommend against
PSA-based prostate cancer
Weaknesses:
screening.
 Prostate cancer
 American Cancer society
questionnaire as not
recommends that decisions
validated and requires
about prostate cancer
further study to
screening be made in a setting
authenticate.
of shared decision making DA may be different due
this setting decisions are made
to varying education
by patients in conjunction with
levels.
provider considering current
scientific evidence as well as
Why included:
the values and preferences of
 Completed at primary
the individual patient
care offices.
 American Urological
 Includes components of
Association recommends that
SDM.
in men aged 55-69 yrs. SDM

Light of the Whole:
How relates:
 DA alone is an
inadequate
substitute for a
direct
conversation
between patient
and provider.
Similar:
 Compared the
use of a DA
alone vs. DA
with SDM.
 Occurred in
Primary Care
Setting.
Differs:
 Looking at long
term and shortterm provider
relationship.
Level of Evidence:
 Level I
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is the preferred model to
determine whether patients
should undergo PSA-based
screening for prostate cancer.
Decision aids (DA) aim to
underscore the exact decision
that needs to be made, provide
information about options,
outcomes, risks, benefits and
clarify personal values.
DA initially designed to
complement rather than
replace counseling by a
provider
Time constraints further
impact primary care practices
they are increasingly
employed as independent
sources of information despite
seldom superiority to
physician judgement

Type:
 Randomized Control Study
Purpose:
 Evaluate whether a DA with
or without SDM during a
primary care visit influenced
knowledge of prostate cancer
screening and rates of PSAbased prostate cancer
screening, stratifying,




Provides key limitations
of SDM and key
advantages of SDM.
Provides what a decision
aid is.
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outcomes by short term
provider relationship and
long-term provider
relationship.
Main Findings:
 3 intervention groups- usual
care (UC), DA alone and
SDM and DA used together
 Patients in DA + SDM were
significantly more likely to
report discussing the
possibility of diagnostic
procedure or surgery
compared to those in UC
 DA group significantly less
likely to report that they
always felt encouraged to
discuss all health concerns.
 DA+SDM group answered
more questions correctly than
the UC group.
Conclusions:
 Providing patients, a DA
without a personal interaction
resulted in a greater chance of
undergoing PSA-based
screening without improving
knowledge about screening or
understanding of the
consequences of this decision.
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DA + SDM were more likely
to report that they had
discussed the possibility of a
procedure or intervention
during their visit compared to
DA alone.

Roland, K. B., Milliken, E. L., Rohan, E.
Main Points:
A., DeGroff, A., White, S., Melillo, S.,
 CHWs and patient navigators
Rorie, W. E., Signes, C.-A. C., & Young, P.
(PN) work to address
A. (2017). Use of community health
disparities and improve cancer
workers and Patient navigators to
outcomes through education,
IMPROVE cancer outcomes among
connecting patients to and
patients served by Federally qualified
navigating them through the
HEALTH Centers: A systematic literature
health care system, supporting
review. Health Equity, 1(1), 61–76.
patient adherence to screening
https://doi.org/10.1089/heq.2017.0001
and diagnostic services and
providing social support and
linkages to financial and
community resources.
 CHW/PN efforts have led to
increase in cancer screening
and timely completion of
diagnostic follow-up and
cancer treatment initiation.
Type:
 Systemic Literature Review
Purpose:
 First to identify studies that
evaluated the effectiveness of
these interventions in
addressing cancer prevention

Strengths:
 All articles reviewed
were written in the U.S.
 All articles focused on
cancer.
 24 articles reviewed
Weaknesses:
 CHW/PN were more
often supervised by
research project
manager or study
investigator.
Why included:
 Explained CHW/PN
intervention
characteristics.

Light of the Whole:
How relates:
 CHWs increase
cancer screening
and timely
completion of
diagnostic
follow-up and
cancer treatment.
Similar:
 Discussed the
use of CHW.
 Completed in
primary care
setting.
Differs:
 Discusses
diagnostic
follow-up and
treatment with
CHWs.
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and control disparities among
the medically underserved
(increasing screening,
reducing time to diagnosis and
treatment, and reducing
barriers to care).
To subsequently describe the
components and
characteristics to those
intervention development and
evaluation.

Main Findings:
 All studies but 2 reported
significant positive outcome
from the CHW/PN
intervention.
 Screening rates improved for
women overdue for a
mammogram or never
screened, women at risk for
inadequate pap test screening
and follow-up, and men and
women noncompliant with
colorectal cancer screening
guidelines after participating
in CHW/PN interventions.
Conclusions:
 CHW/PN programs can
improve completion and
timeliness of breast, cervical
and colorectal cancer

Level of Evidence:
 Level I
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Allen, J. D., Filson, C. P., & Berry, D. L.
(2020). Effect of a prostate cancer
screening decision aid for African
American men in primary care
settings. Cancer Epidemiology Biomarkers
& Prevention, 29(11), 2157–2164.
https://doi.org/10.1158/1055-9965.epi-200454

screening and diagnosis
among the medically
underserved populations
served by FQHCs.
 CHW/PN partnership can
serve unique needs of diverse
and underserved communities
in both clinical and
community settings.
 CHW/PN interventions are
effective in increasing cancer
screening and the timeliness of
diagnostic resolution among
medically underserved
populations
Main Points:
Strengths:
Light of the Whole:
How relates:
 SDM about prostate cancer
 Study approved by the
screening is recommended but
International Review
 DA developed to
does not always occur.
Boards at Tufts
prepare men to
University, Emory
 DA had interactive segments
engage in SDM
University school of
and provided individualized
in primary care
medicine and the Atlanta
assessment of prostate cancer
settings.
VA medical Center.
risk.
 Immediately after clinical
Similar:
Weaknesses:
visit, patients reported to the
 Describes goals
 Relatively small sample.
degree to which they were
of DA.
engaged by their provider in
 Did not randomly assign
 Used a pre/post
SDM.
patients to receive the
evaluation
DA- cannot infer
 All organizations agree that
causality.
men should be offered the
design.
PSA test only after being fully
Why included:
informed about the potential
risks and benefits of screening
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and discussing decisions with
their health care provider
(SDM).
Barriers to SDM include short
duration of medical
appointments and the need to
prioritize a range of health
concerns.
DA’s can effectively increase
patients’ knowledge about
PrCA screening, promote
confidence in the ability to
engage in decision-making
with provider and decrease
decisional conflict.
DA’s advantage could be
administered prior to medical
visits and could increase
meaningful patient
engagement in decision
making.

Type:
 Quasi-experimental study.
Purpose:
 Determine the impact of an
online DA on patients’ ability
to engage in decision-making
about prostate cancer
screening.
Main Findings:




Provided individualized
 Completed in
assessment of prostate
primary care
cancer risk.
settings.
Only 23% of men who
undergone PSA testing
Differs:
within the past year had
 DA was
discussed the advantages
delivered via
and disadvantages of
video following
screening with their
the format of a
health care provider.
popular TV
show.
Level of Evidence:
 Level II
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Following visit patients
completed questionnaire that
assessed their perceived
involvement in SDM with
their provider.
Nearly all reported that they
would choose to undergo
screening for PrCA before
using DA, significantly less
likely to choose to undergo
screening after using DA.
Most felt that the DA had
prepared them “very
well/well” for SDM with their
provider.
PCSPrep can help to prepare
men to engage in SDM when
administered in primary care
clinics.

Conclusions:
 Additional research will be
needed to better understand
the feasibility of implementing
the DA in primary care from
the perspectives of providers
and clinic staff.
 Patient reports of engagement
of SDM were suboptimal.
 Provider interventions such as
educational materials and
reminder systems could
improve communication skills

85
and intention to engage
patients in preferencesensitive decisions.
Owens, O. L., Wooten, N. R., & Tavakoli,
A. S. (2019). Development and initial
PSYCHOMETRIC evaluation of the
COMPUTER-BASED prostate cancer
Screening decision aid acceptance scale for
African American men. BMC Medical
Research Methodology, 19(1).
https://doi.org/10.1186/s12874-019-0776-y

Main Points:
Strengths:
 Recommendations for PrCA
 Study approved by IRB.
are not clear cut and evolved
 Completed in the U.S.
over the past two decades.
 Large sample of
 Recommend that men make an
participants.
informed decision with a
healthcare provider about
Weaknesses:
whether to receive PrCA
 Pretest was only
screening
conducted with 2
 USPSTF released draft
participants.
recommendations that are
more consistent with agencies Why included:
that support informed decision
 Provides more
making.
information on another
 To engage in informed
article in this literature
decision-making AA men,
review.
need plain language PrCA
knowledge information and
adequate decision selfefficacy.
 Questions were modified to
refer generally to a CBDA as
opposed to generally referring
to a “system”.

Light of the Whole:
How relates:
 Shows that this
specific DA
shows promise
as playing a key
role in increasing
knowledge and
assisting in
informed PrCA
screening
decision making.

Type:
 Randomized Control Study.

Level of Evidence:
 Level I

Purpose:

Similar:
 Pre/posttest
given.
 Focuses on
prostate cancer.
Differs:
 DA was
completely
computer based.

86


To evaluate the psychometric
properties of the 24-item
Computer Based Prostate
Cancer Screening decision aid
Acceptance scale in AA men
using CBDA for informed
PrCA screening decision
making.

Main Findings:
 Acceptance of the use of
CBDA for PrCA screening.
Conclusions:
 Computer Based Prostate
Cancer screening decision aid
acceptance scale shows
promise as playing a key role
in increasing PrCA knowledge
and assisting in informed
PrCA screening decision
making among AA men.
Makarov, D., Feuer, Z., Ciprut, S.,
Martinez-Lopez, N., Fagerlin, A., Shedlin,
M., Gold, H. T., Li, H., Lynch, G., Warren,
R., Ubel, P., & Ravenell, J. (2021).
Randomized trial of community Health
Worker-led DECISION coaching to
PROMOTE shared decision making for
prostate cancer Screening among black
male patients and their providers.
https://doi.org/10.21203/rs.3.rs-128422/v2

Main Points:
 Nationally representative
study of men considering PSA
screening reported that only
half were asked their
preferences, and pros and cons
of screening were discussed in
only 32% of the time.
 Decision coaching is the
process by which a non-

Strengths:
Light of the Whole:
 Study completed in NYS
How relates:
 4 FNPs assisted as
 Focused on
providers in the study.
 Used American Cancer
Prostate Cancer
Society prostate cancer
screening and
early detection decision
SDM.
Aid.
Weaknesses:
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healthcare provider coach
provides a patient with
individualized, nondirective
guidance to meet decision
making needs in preparation
for consultation with a
healthcare provider.
Type:
 Randomized control trial
Purpose:
 To evaluate the efficacy of a
community healthcare worker
(CHW)- led decision-coaching
program to facilitate SDM for
prostate cancer screening
among black men in the
primary care setting with the
aim of improving/optimizing
decision quality.
Main Findings:
 CHWs seem ideally suited as
decision coaches in primary
care practices seeking to
facilitate SDM for PSA
screening among black men.
Conclusions:
 Ongoing study, anticipated
that there will be an
improvement in awareness,




Study is currently
ongoing.
Completion anticipated
for March 2023.

Why included:
 Different approach to
SDM



Used in primary
care settings.

Similar:
 Facilitates SDM
for prostate
cancer screening
decisions.
Differs:
 DA is provided
in mail.
 CHW led
decision occurs
1hr prior to
appointment.
Level of Evidence:
 Level I
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knowledge, support, and
efficacy to reduce the impact
of chronic disease and cancer
in underserved populations
when CHW is used.
Allen, J. D., Reich, A., Cuevas, A. G., &
Ladin, K. (2019). Preparing African
American men to make informed prostate
cancer screening decisions: Development
and pilot testing of an interactive online
decision aid (preprint).
https://doi.org/10.2196/preprints.15502

Main Points:
 DA are promising means to
prepare men to engage in
SDM and can be administered
before a clinical visit.
 Development and pilot testing
of an interactive individually
tailored web-based DA
designed specifically for AA
men.
Type:
 Quasi-experimental Study.
Purpose:
 Aimed to describe the
development and pilot testing
of an interactive web-based
decision aid; prostate cancer
screening preparation
(PCSPrep) for African
American men designed
informed decision making for
prostate cancer screening.
Main Findings:
 DAs found to be effective
interventions to complement
patient/provider engagement
in SDM by providing patients

Strengths:
 Completed in the U.S.
 Addressed issues with
false-positives tests
results in the DA.
Weaknesses:
 Small convenience
sample with no control
group.
Why included:
 Decision aid that is
discussed is for prostate
cancer screening.

Light of the Whole:
How relates:
 Proves that DA’s
have been found
to be effective
interventions to
complement
patient/provider
engagement in
SDM.
Similar:
 Survey questions
included
incidence of
prostate cancer,
risk factors,
screening
modalities.
 Used a decision
Aid.
Differs:
 Provided
assistance during
completion of
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with information needed to
assess their options and
examine their values as they
relate to those options.
 It has been suggested that
offering DAs for prostate
cancer screening outside of a
clinical setting may be
particularly important to AA
men who report difficulty
communicating with medical
providers and may have a high
level of medical mistrust.
 PCSPrep to be feasible to
administer in community
settings even among those
who reported low levels of
computer skills.
 High levels of agreement
when asked the extent to
which PCSPrep helped
prepare them to organize their
thinking, make decision and
have conversations about
screening with their provider.
Conclusions:
 Decision support may improve
the accuracy of disease risk
among this population and at
the same time enable men to
make decisions without undue
internal conflict.

survey
completion.
Level of Evidence:
 Level II
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Alizadeh-Sabeg, P., Mehrabi, E.,
Nourizadeh, R., Hakimi, S., & Mousavi, S.
(2021). The effect of motivational
interviewing on the change of breast cancer
screening behaviors among Rural Iranian
women. Patient Education and
Counseling, 104(2), 369–374.
https://doi.org/10.1016/j.pec.2020.08.011

Main Points:
 Education may raise women’s
awareness of breast cancer,
but it is not adequate alone.
 61% of women in Saudi
Arabia had high knowledge of
mammography but less than
1/3 have had a mammography
preformed.
 Regular screening depends
largely on motivational
factors, especially one’s
perception of the risk of
disease and impact of
screening behaviors on
reducing the risk of breast
cancer.
 MI is considered as a clientcentered approach aimed at
improving the motivation of
clients to change their
behavior.
Type:
 Randomized Control Trial
Purpose:
 To determine the effect of
motivational interviewing
(MI) on the change of breast
cancer screening behaviors
among rural Iranian Women
Main Findings:
 Most participants were at the
contemplation stage before the

Strengths:
 Provided educational
booklet to participants
along with counseling
sessions.
 Counseling provided by
certified counselor in
MI.
Weaknesses:
 Not completed in U.S.
 Done on breast cancer
not prostate cancer.
 Did not provide
education during MI.
Why included:
 Shows benefits of
motivational
interviewing.

Light of the Whole
How relates:
 Motivational
Based
counseling
increased
motivation for
displaying breast
cancer screening
behaviors.
Similar:
 Participants from
low
socioeconomic
status and lack of
easy access to
advanced
screening
facilities.
Differs:
 Participants
attended
educational
sessions and 4
weekly
consecutive MI
sessions.
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intervention while at the end
of most individuals in the
intervention group entered
action stage for self-breast
checking and CBE.
 Only 16 participants entered
action phase for mammogram.
Conclusions:
 MI-based counseling
increased the Iranian rural
women’s motivation for
displaying breast cancer
screening behaviors.
Stacey, D., Kryworuchko, J., Bennett, C.,
Murray, M. A., Mullan, S., & Légaré, F.
(2012). Decision coaching to Prepare
patients for making health
decisions. Medical Decision Making, 32(3).
https://doi.org/10.1177/0272989x12443311

Main Points:
Strengths:
 Decision coaching aims to
 Compared decision
develop patients’ confidence
coaching, decision aid
and skills in deliberating about
and neither.
options and helps prepare
patients to discuss decisions
Weaknesses:
with their practitioner.
 Not within 5 years.
 Decision coaching refers to
 Did not include articles
the process by which a
that had decision
supportive and knowledgeable
coaching without having
health professional provides a
a DA.
patient with individualized
nondirective guidance to meet Why included:
decision-making needs in
 Trials included in the
preparation for consultation
study some focused on
with the person responsible for
decisions related to
ultimately sharing the decision
prostate cancer
with patient.
screening.



Sessions were in
groups of 5-7
participants.

Level of Evidence:
 Level I

Light of the Whole:
How relates:
 Decision
coaching by
someone within
the health care
team is a strategy
for ensuring that
DA are provided
and discussed
with patients.
Similar:
 Measured
knowledge
improvement
with use of
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Type:
 Systemic Review of
Randomized Control Trial
Purpose:
 To explore characteristics and
effectiveness of decision
coaching evaluated within
trials of patient decision aids
(PtDAs) for health decisions.
Main Findings:
 Coaching compared with
usual care improved
knowledge.
 Coaching plus PtDAs with
usual care improved
knowledge and participation
in decision making without
reported dissatisfaction.
 Coaching versus usual carewomen had higher knowledge
of breast cancer genetic testing
with decision coaching over
those who only had usual care.
 No difference in measured
knowledge between coaching
and PtDA alone.
 More consistent values seen in
women exposed to coaching
vs PtDA alone.



4 trials measured
satisfaction.

coaching and a
DA.
Differs:
 Did not
specifically
address what
was being
educated (i.e.,
prostate cancer
screening).
Level of Evidence:
 Level I
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Coaching plus PtDA vs PtDA
alone there was no difference
in Prostate cancer screening.

Conclusions:
 Growing interest in decision
coaching.
 Decision coaching appears to
improve knowledge .
Palmas, W., March, D., Darakjy, S.,
Findley, S. E., Teresi, J., Carrasquillo, O.,
& Luchsinger, J. A. (2015). Community
health worker interventions to improve
glycemic control in people with diabetes: A
systematic review and metaanalysis. Journal of General Internal
Medicine, 30(7), 1004–1012.
https://doi.org/10.1007/s11606-015-3247-0

Main Points:
 Education from a certified
diabetes educator.
 Components in the articles
differed substantially.
Type:
 A Systematic Review and
Meta-Analysis
Purpose:
 To review the efficacy of
community health worker
interventions to improve
glycemia in people with
diabetes.
Main Findings:
 CHW interventions lasting at
least 12 months result in
modest reduction in Alc,
compared to usual care.

Strengths:
 Used an outpatient
setting.
 Primarily used
MEDLINE for literature
search.

Light of the Whole:
How relates:
 CHW
interventions
reduced the A1c
in participants.

Weaknesses:
 Studied mostly minority
populations
 Detailed data describing
the exact number of
CHW participant
encounters was not
available for several
studies.

Similar:
 CHW
intervention
resulted
positively
(lowered Alc).
 Targeted
participants in
low
socioeconomic
stratum.

Why included:
 Integrated CHW
intervention with
patients PCP.

Differs:
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Alaofè, H., Asaolu, I., Ehiri, J., Moretz, H.,
Asuzu, C., Balogun, M., Abosede, O., &
Ehiri, J. (2017). Community health workers
in Diabetes prevention and management in
developing countries. Annals of Global
Health, 83(3-4), 661.
https://doi.org/10.1016/j.aogh.2017.10.009

Studies with more visit
intensive CHW protocol might
have shown greater efficacy.



Studied lowering
of Hemoglobin
Alc.

Conclusions:
 CHW interventions showed a
modest reduction in Alc
compared to usual care.

Level of Evidence:
 Level I

Main Points:
Strengths:
 Outcomes included increased
 Gave
knowledge of T2DM
inclusion/exclusion
symptoms and prevention
Criteria.
measures; increased adoption
of treatment-seeking and
Weaknesses:
prevention measures;
 Limited research
increased medication
reviewed.
adherence and improved
 Study not done in the
fasting blood sugar, glycated
U.S.
hemoglobin, and BMI.
 Pt. education- an inexpensive
Why included:
and effective diabetes
 Touched based on CHW
management option is not
and high-income
practiced routinely.
countries- have also
 CHWs serve as bridges among
improved health
their ethnic, cultural, or
behaviors & outcomes.
geographic communities and
 CHW improve
health care providers.
knowledge and health
outcomes.
Type:
 Literature review

Light of the Whole:
How relates:

Purpose:



Shows positive
outcomes with
the use of CHW.

Similar:
 Increased
awareness of
symptoms and
prevention
measures.
Differs:
 Articles focused
on T2DM.
 Focused on
descriptions of
training and
supervision
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To critically appraise evidence
regarding the effectiveness of
CHW interventions for
prevention and management of
type 2 diabetes mellitus
(TDM) in low-and middleincome countries (LMICs).

Main Findings:
 Positive outcomes in 7 out of
10 articles.
 One article had health
volunteers provide nutritional
education and established
appropriate daily exercise
activities for 3 months- mean
score for health promotion
behavior was significantly
higher after intervention.
Conclusions:
 CHW have potential to
improve knowledge, health
behavior and health outcomes
related to prevention and
management of T2DM in
LMICs.
 Further research is needed into
the influence of CHWs on
disease awareness, health
behaviors and health
outcomes.

procedures for
CHWs.
Level of Evidence:
 Level V
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Portillo, E. M., Vasquez, D., & Brown, L.
D. (2020). Promoting Hispanic Immigrant
health via community health workers and
motivational interviewing. International
Quarterly of Community Health
Education, 41(1), 3–6.
https://doi.org/10.1177/0272684x19896731

Main Points:
 Examines three innovative
strategies designed to
overcome the health
disparities Hispanic
immigrants face; the use of
CHW, vouchers for
preventative health services
and motivational interviewing
(MI)
 Strategies were implemented
in a health promotion program
called Healthy Fit.
 CHW conducted brief MI
aimed at enhancing the
participants intrinsic
motivation to follow through
and complete health behavior
changes.
Type:
 Program Evaluation
Purpose:
 Examine three innovative
strategies designed to
overcome the health
disparities Hispanic
immigrants face.
Main Findings:
 CHW help participants conner
with liaisons who serve as a

Strengths:
 Discusses the use of
CHW and MI.

Light of the Whole:
How relates:
 CHWs increase
access to
Weaknesses:
healthcare by
 Specifically looking at
communicating
Healthy Fit program.
sensitive
information,
Why included:
advocating on
 CHW are conducting the
participates
motivational interview.
behalf and
creates a
partnership with
participants.
Similar:
 Healthy fit
program reaches
out to those in
low
socioeconomic
areas.
Differs:
 Used
foronovelas
which are health
education comics
to provide
education.
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bridge between health care
providers and the community.
Use of MI enriches
conversation between CHW
and participants, helping
participants address health
barriers.

Focuses on the
Healthy Fit
program.

Level of Evidence:
 Level V

Conclusions:
 Combination of all three
strategies makes healthy fit a
promising low-cost program
which promotes wellness in an
underserved immigrant
population.
Brandford, A., Adegboyega, A., Combs, B.,
& Hatcher, J. (2018). Training community
health workers in motivational interviewing
to promote cancer screening. Health
Promotion Practice, 20(2), 239–250.
https://doi.org/10.1177/1524839918761384

Main Points:
 CHWs are increasingly being
used in cancer prevention and
control efforts.
 CHWs are frontline public
health workers who have a
close understanding of the
community.
 Goal of CHWs is to increase
health knowledge and selfsufficiency through a range of
activities such as outreach,
community education, social
support, and advocacy efforts.
Research Type:

Strengths:
 Completed in the U.S.
Weaknesses:
 Limited information on
training of all CHWs.
Why included:
 Includes training for
CHW with MI.
 Discussed CHW with
cancer prevention.

Light of the Whole:
How relates:
 CHWs agreed
that the use of
MI is feasible
and valuable in
promoting
cancer
screenings in
underserved
populations.
Similar:
 CHW goals are
to increase
health
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Literature Review.

Purpose:
 To describe the feasibility of
training CHWs to deliver
motivational interviewing
intervention to promote cancer
screening in underserved
populations.
Main Findings:
 Participants receiving the MI
intervention tended to be more
specific and detailed in listing
tangible barriers to
mammography.
 Challenges making the
training meaningful for all
levels of CHWs.
 MI is a successful and feasible
technique for a CHW to
promote cancer screening.
 Training increased confidence
and provided the CHWs with
a skill set that could be
adapted to meet the needs of
the community served.
Conclusions:
 Most powerful strategies to
address cancer disparities is
the use of CHWs to influence

knowledge and
self-efficacy.
Differs:
 Focuses on
training for
CHW to conduct
motivational
interviewing.
Level of Evidence:
 Level V
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behavior surrounding cancer
screenings.
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Appendix B: Decision Aid
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Appendix C: COMRADE Tool
Satisfaction with Communication
1. The doctor made me aware of the different treatments available.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

2. The doctor gave me the chance to express my opinions about the different treatments available.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

3. The doctor gave me the chance to ask for as much information as I needed about the different
treatment choices.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

4. The doctor gave me enough information about the treatment choices available.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

5. The doctor gave enough explanation of the information about treatment choices.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Disagree

Strongly Disagree

6. The information given to me was easy to understand.
Strongly Agree

Agree

Neutral

7. I know the advantages of treatment or not having treatment.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

8. I know the disadvantages of treatment or not having treatment.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

9. The doctor gave me a chance to decide which treatment I thought was best for me.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

10. The doctor gave me a chance to be involved in the decisions during the consultation.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree
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Confidence in Decision
1. Overall, I am satisfied with the information I was given.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

2. My doctor and I agreed about which treatment (or no treatment) was best for me.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Disagree

Strongly Disagree

3. I can easily discuss my condition again with my doctor.
Strongly Agree

Agree

Neutral

4. I am satisfied with the way in which the decision was made in the consultation.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

5. I am sure that the decision made was the right one for me personally.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

6. I am satisfied that I am adequately informed about the issues important to the decision.
Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Neutral

Disagree

Strongly Disagree

Disagree

Strongly Disagree

Disagree

Strongly Disagree

Disagree

Strongly Disagree

7. It is clear which choice is best for me.
Strongly Agree

Agree

8. I am aware of the treatment choices I have.
Strongly Agree

Agree

Neutral

9. I feel an informed choice has been made.
Strongly Agree

Agree

Neutral

10. The decision shows what is important to me.
Strongly Agree

Agree

Neutral
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Appendix D: Knowledge Questionnaire

105
Appendix E: Budget Table
Cost Activity

Amount

Type

Meeting and Presentation
Preparation

$750.00

Direct/Fixed

*Calculated based on the average NP
hourly rate in the geographical area
for 10 hours of preparation
$559.5

Direct/Fixed

30-Minute Introduction
Meeting and 1-Hour Training
Session Attendance
(2 NPs, 1 RN, 2 LPN 1 office
manager, 2 secretaries)
1-Hour NP Video Training

* Calculated based on the average
hourly rate in the geographical area
$180.00

Direct/Fixed

$69.50

Direct/Fixed

*Calculated based on $0.08 per page
printed front & back, $0.15 per page
for color printed front & back & $1.00
per folder for 50 patients
$150.00

Direct/Fixed

*Calculated based on the average rate
for a videographer in the geographical
area
$0.64

Direct/Fixed

*Calculated based on $0.08 per page
print front and back
$33.00

Direct/Fixed

Recruitment Flyers

*Calculated based on the average IT
hourly rate in the geographical area
for 1 hour of assistance
$4.00

Direct/Fixed

Total Costs

*Calculated based on $0.08 per page
printed front only (printed 50 flyers)
$1,746.64

Variable

Patient Materials
(Decision Aid, Pre- & PostQuestionnaire, COMRADE
Tool & folders)

1-Hour Videographer

Staff Education Materials
(Staff Education Sheet)

1-Hour IT
(Set Up OR Code)
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Benefit Gains

Amount

Type

Billable 30–45 minute Nurse
Practitioner visit.

$5,100.00

Direct/ fixed

*Calculated based on the
average rate of billable hour
& 30 patients.
$13,100

Direct/ fixed

*Calculated based on cost of
radiation for 30 days verses
radical prostatectomy.
$2,550.00

Direct/ fixed

*Calculated based on the
average rate of billable hour
& one physical a year.
$5,100.00

Direct/ fixed

Total Gains

*Calculated based on the
average rate of billable hour
& 30 recruitments.
$25,850.00

Variable

Total Costs

$1,746.64

Total Benefits

$25,850.00

Saved Insurance Costs

Patient Retention from
Satisfaction. (15 patients will
transfer primary care to this
office)
Patient Recruitment. (Each
participant will recruit 1 one
friend to participant in study)

Cost/Benefit Amount

$24,103.36
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Appendix F: Recruitment Flyer

Prostate Cancer Are YOU at
Risk?

 Are you a fireman, police officer or
detective?
 Are you concerned about your risk of
developing prostate cancer?
Watch this short YouTube Video to find
out more information about this study and
to potentially participate.
Scan QR Code to be redirected to the YouTube Video.
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Appendix G: Recruitment Video

Information that will be include in the YouTube video that will recruit participants.

Information about Prostate Cancer.




What is prostate cancer?
o Prostate cancer is a form of cancer that begins in the gland cells of the prostate,
and it is only found in males.
Risk factors:
o Age, family history of prostate cancer, ethnicity and recently occupation.
Statistics on prostate cancer:
o In 2018 211,893 were diagnosed with prostate cancer and 31,488 men died from
the disease.

Information about the Study and who can participate.






What the program consists of:
o The study will consist of one nurse practitioner led decision coaching session.
o You will be asked to complete documentation that will establish your knowledge
of prostate cancer and evaluate your satisfaction with the decision coaching
session and your confidence in decision making.
o At the completion of decision coaching session, you will be asked if you would
like to have your PSA tested.
o All information will remain confidential.
Who can participate in the study?
o Males greater than age 40
o Protective Service Occupation
o Volunteer Firemen
What is a Protective service occupation?
o Firefighters, policemen and detective.
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Appendix H: Staff and Nurse Education
taff Education












Patients’ paperwork (informed consent, pre- and post- questionnaire, & COMRADE tool)
will be identified by a number associated with their chart to maintain confidentiality.
o Example: Name- John Doe- #0046
Nurse practitioner led decision coaching will provide education to protective service
occupations about prostate cancer and PSA testing.
The goal of this proposal is to improve knowledge about prostate cancer, increase the
number of individuals getting PSA testing done.
Other goals include improved satisfaction with shared decision making and improved
confidence in decision making.

Frequently check google forms email for responses to participate in study.
When responses are received, reach out to individual who completed the google form.
Educated them on purpose of study and review informed consent.
Send informed consent and pre-questionnaire to patients after phone conversation.
During decision coaching frequently refresh EMR to see if PSA testing was ordered, if so, go to
patients’ room and draw labs for the PSA testing.
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Appendix I: Nurse Practitioner Education

What you will be educating the participants:
 Anatomy & Function
o Prostate gland is a reproductive organ located below the bladder.
o The prostate gland makes some of the fluid that is part of semen.
 Risk factors
o Age increases your risk of developing prostate cancer.
o African American ethnicity has higher diagnosis rate than Caucasians.
o Family history of prostate cancer increases your risk of being diagnosed with
prostate cancer.
 Screening
o PSA stands for prostate specific antigen; it is a protein made by the prostate gland
and can be found in the blood. An increased PSA may indicate prostate cancer.
o DRE also known and digital rectal exam is done to establish if any nodules or
tumors can be felt on the prostate gland.
o A biopsy of the prostate gland is the only way to properly diagnose prostate
cancer.
o Prostate cancer biopsy is a procedure that will remove samples of suspicious
tissue from the prostate gland.
o PSA testing and DRE are not definitive in diagnosing prostate cancer.
o Risks related to PSA testing.
 Symptoms
o Sign and symptoms of prostate cancer include trouble urinating, decreased force
in the stream of urine, blood in urine or semen, bone pain, losing weight without
trying and erectile dysfunction.
o Early stages of prostate cancer you may not have any signs or symptoms.
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Appendix J: Data Tracking Sheet

PSA
Testing
Completed
#01
#02
#03
#04
#05
#06
#07

Yes

No

Referred
to
Urology

Yes

No

Followed
Up with
Urology

Yes

No

